<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">arthyper</journal-id><journal-title-group><journal-title xml:lang="ru">Артериальная гипертензия</journal-title><trans-title-group xml:lang="en"><trans-title>"Arterial’naya Gipertenziya" ("Arterial Hypertension")</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1607-419X</issn><issn pub-type="epub">2411-8524</issn><publisher><publisher-name>Antihypertensive League</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.18705/1607-419X-2008-14-3-220-232</article-id><article-id custom-type="elpub" pub-id-type="custom">arthyper-1232</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОР</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEW</subject></subj-group></article-categories><title-group><article-title>Эндогенные кардиотонические стероиды: клинические перспективы</article-title><trans-title-group xml:lang="en"><trans-title>Endogenous cardiotonic steroids:
clinical perspectives</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Федорова</surname><given-names>О.</given-names></name><name name-style="western" xml:lang="en"><surname>Fedorova</surname><given-names>O. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Коростовцева</surname><given-names>Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Korostovtseva</surname><given-names>L.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шапиро</surname><given-names>Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Shapiro</surname><given-names>J.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Багров</surname><given-names>А.</given-names></name><name name-style="western" xml:lang="en"><surname>Bagrov</surname><given-names>A.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Национальный институт старения, Национальные институты здоровья</institution><country>Россия</country></aff><aff xml:lang="en"><institution>National Institute of Aging, National Institutes of Health</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Федеральный центр сердца, крови и эндокринологии им. В.А. Алмазова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>V.A. Almazov Heart, Blood and Endocrinology Center</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Медицинский колледж Университета Толедо</institution><country>Россия</country></aff><aff xml:lang="en"><institution>College of Medicine, University of Toledo</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2008</year></pub-date><pub-date pub-type="epub"><day>28</day><month>06</month><year>2008</year></pub-date><volume>14</volume><issue>3</issue><fpage>220</fpage><lpage>232</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Федорова
                 О.V., Коростовцева
                 Л., Шапиро
                 Д., Багров
                 А., 2008</copyright-statement><copyright-year>2008</copyright-year><copyright-holder xml:lang="ru">Федорова
                 О., Коростовцева
                 Л., Шапиро
                 Д., Багров
                 А.</copyright-holder><copyright-holder xml:lang="en">Fedorova
                 O.V., Korostovtseva
                 L., Shapiro
                 J., Bagrov
                 A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://htn.almazovcentre.ru/jour/article/view/1232">https://htn.almazovcentre.ru/jour/article/view/1232</self-uri><abstract><p>В настоящее время выявлено несколько эндогенных кардиотонических стероидов, или дигиталис-подобных факторов, у человека; среди них уабаин, относящийся к классу карденолидов, и маринобуфагенин, из класса буфадиенолидов, изучены наиболее подробно. Физиологической функцией кардиотонических стероидов является поддержание гомеостаза натрия и регуляция натрийуреза на уровне почек. Эндогенные кардиотонические стероиды, связываясь с Na/K-АТФ-азой, не только ингибируют трансмембранный транспорт моновалентных катионов, а также активируют Src-EGF-опосредованный путь клеточной сигнализации. У крыс линии Dahl с соль-индуцированной артериальной гипертензией эндогенный уабаин действует как нейрогормон, стимулируя высвобождение маринобуфагенина, обладающего натриуретическим и сосудосуживающим свойствами. У ряда больных полиморфизм гена альфа-аддуцина на фоне повышения уровня эндогенного уабаина приводит к активации Na/K-АТФ-азы в почечных канальцах и ретенции натрия, что является триггером развития гипертензии. Эндогенные кардиотонические стероиды также вносят вклад в патогенез хронической сердечной недостаточности, преэклампсии и сахарного диабета. Иммунонейтрализация, антагонизм рецепторов кардиотонических стероидов, ингибирование протеин-киназы С и активация протеин-киназы G являются потенциальными подходами к фармакологическому антагонизму нежелательных эффектов кардиотонических стероидов.
            </p></abstract><trans-abstract xml:lang="en"><p>Several endogenous digitalis-like cardiotonic steroids (CTS) have been identified in humans, including endogenous ouabain, a cardenolide, and marinobufagenin which belongs to a class of bufadienolides. The main function of CTS is maintenance of sodium homeostasis and regulation of natriuretic function. Endogenous cardiotonic steroids bind to the Na/K-ATPase and exhibit two kinds of effects, inhibition of transmembrane transport of monovalent cations, and induction of a complex cascade of cell signaling. In Dahl salt-sensitive rats with NaCl-induced hypertension, endogenous ouabain, acting as a neurohormone stimulates adrenocortical marinobufagenin, which raises blood pressure via inhibition of vascular Na/K-ATPase. In a subgroup of hypertensive subjects, which possess a polymorphism of alpha-adducin gene, elevated levels of endogenous ouabain activate renotubular Na/K-ATPase and induce renal sodium retention. Elevated levels of CTS also contribute to pathogenesis of congestive heart failure, preeclampsia, and diabetes mellitus. The approaches to pharmacological antagonism of the effects of CTS include blockade of CTS receptor site on the Na/K-ATPase, immunoneutralization, and interactions at the levels of Na/K-ATPase phosphorylation/dephosphorylation by protein kinases С and G.
            </p></trans-abstract><kwd-group xml:lang="ru"><kwd>эндогенные кардиотонические стероиды</kwd><kwd>соль-индуцированная гипертензия</kwd></kwd-group><kwd-group xml:lang="en"><kwd>Na/K-АТФ-аза</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Ritz E. The history of salt-aspects of interest to the nephrologist. Nephrol Dial Transplant 1996; 11:969-975.</mixed-citation><mixed-citation xml:lang="en">Ritz E. The history of salt-aspects of interest to the nephrologist. Nephrol Dial Transplant 1996; 11:969-975.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Meneton P, Jeunemaitre X, de Wardener HE, MacGregor GA. Links between dietary salt intake, renal salt handling, blood pressure, and cardiovascular diseases. Physiol Rev 2005;85(2):679-715.</mixed-citation><mixed-citation xml:lang="en">Meneton P, Jeunemaitre X, de Wardener HE, MacGregor GA. Links between dietary salt intake, renal salt handling, blood pressure, and cardiovascular diseases. Physiol Rev 2005;85(2):679-715.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Taubes G. The (political) science of salt. Science 1998;281:898-901.</mixed-citation><mixed-citation xml:lang="en">Taubes G. The (political) science of salt. Science 1998;281:898-901.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">De Wardener HE, MacGregor GA. Sodium and blood pressure. Curr Opin Cardiol 2002;17:360-367.</mixed-citation><mixed-citation xml:lang="en">De Wardener HE, MacGregor GA. Sodium and blood pressure. Curr Opin Cardiol 2002;17:360-367.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Weinberger MH. Pathogenesis of salt sensitivity of blood pressure. Curr Hypertens Rep 2006;8:166-170.</mixed-citation><mixed-citation xml:lang="en">Weinberger MH. Pathogenesis of salt sensitivity of blood pressure. Curr Hypertens Rep 2006;8:166-170.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Ritz E, Dikow R, Morath C, Schwenger V. Salt - a potential 'uremic toxin'? Blood Purif 2006;24:63-66.</mixed-citation><mixed-citation xml:lang="en">Ritz E, Dikow R, Morath C, Schwenger V. Salt - a potential 'uremic toxin'? Blood Purif 2006;24:63-66.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Stamler J, Rose G, Elliott P, Dyer A, Marmot M, Kesteloot H, Stamler R. Findings of the international cooperative INTERSALT study. Hypertension 1991;17 (Suppl 1):19-15.</mixed-citation><mixed-citation xml:lang="en">Stamler J, Rose G, Elliott P, Dyer A, Marmot M, Kesteloot H, Stamler R. Findings of the international cooperative INTERSALT study. Hypertension 1991;17 (Suppl 1):19-15.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med 1997;336(16):1117-1124</mixed-citation><mixed-citation xml:lang="en">Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med 1997;336(16):1117-1124</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">de Wardener HE, Clarkson EM () Concept of natriuretic hormone. Physiol Rev 1985;65:658-759.</mixed-citation><mixed-citation xml:lang="en">de Wardener HE, Clarkson EM () Concept of natriuretic hormone. Physiol Rev 1985;65:658-759.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Kelly RA, Smith TW. Is ouabain the endogenous digitalis? Circulation l992;86:694-697.</mixed-citation><mixed-citation xml:lang="en">Kelly RA, Smith TW. Is ouabain the endogenous digitalis? Circulation l992;86:694-697.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Hansen O. No evidence for a role in signal transduction of Na+/K+-ATPase interaction with putative endogenous ouabain. Eur J Biochem 2003;270:1916-1919.</mixed-citation><mixed-citation xml:lang="en">Hansen O. No evidence for a role in signal transduction of Na+/K+-ATPase interaction with putative endogenous ouabain. Eur J Biochem 2003;270:1916-1919.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Hamlyn JM, Blaustein MP, Bova S, DuCharme DW, Harris DW, Mandel F et al. Identification and characterization of an ouabain-like compound from human plasma. Proc Natl Acad Sci USA 1991;88(14):6259-6263.</mixed-citation><mixed-citation xml:lang="en">Hamlyn JM, Blaustein MP, Bova S, DuCharme DW, Harris DW, Mandel F et al. Identification and characterization of an ouabain-like compound from human plasma. Proc Natl Acad Sci USA 1991;88(14):6259-6263.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Lichtstein D, Gati I, Samuelov S, Berson D, Rozenman Y, Landau L, Deutsch J. Identification of digitalislike соmpounds in human cataractous lenses. Eur J Biochem 1993;216(1):261-268.</mixed-citation><mixed-citation xml:lang="en">Lichtstein D, Gati I, Samuelov S, Berson D, Rozenman Y, Landau L, Deutsch J. Identification of digitalislike соmpounds in human cataractous lenses. Eur J Biochem 1993;216(1):261-268.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Bagrov AY, Fedorova OV, Dmitrieva RI, Howald WN, Hunter AP, Kuznetsova EA, Shpen VM. Characterization of a urinary bufodienolide Na+,K+-ATPase inhibitor in patients after acute myocardial infarction. Hypertension 1998;31(5):1097-1103.</mixed-citation><mixed-citation xml:lang="en">Bagrov AY, Fedorova OV, Dmitrieva RI, Howald WN, Hunter AP, Kuznetsova EA, Shpen VM. Characterization of a urinary bufodienolide Na+,K+-ATPase inhibitor in patients after acute myocardial infarction. Hypertension 1998;31(5):1097-1103.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Komiyama Y, Dong XH, Nishimura N, Masaki H, Yoshika M, Masuda M, Takahashi H. A novel endogenous digitalis, telocinobufagin, exhibits elevated plasma levels in patients with terminal renal failure. Clin Biochem 2005;38(1):36-45.</mixed-citation><mixed-citation xml:lang="en">Komiyama Y, Dong XH, Nishimura N, Masaki H, Yoshika M, Masuda M, Takahashi H. A novel endogenous digitalis, telocinobufagin, exhibits elevated plasma levels in patients with terminal renal failure. Clin Biochem 2005;38(1):36-45.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Schoner W, Scheiner-Bobis G. Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth. Am J Physiol Cell Physiol 2007;293:C509-C536</mixed-citation><mixed-citation xml:lang="en">Schoner W, Scheiner-Bobis G. Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth. Am J Physiol Cell Physiol 2007;293:C509-C536</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Haddy FJ. Role of dietary salt in hypertension. Life Sci 2006;79:1585-1592.</mixed-citation><mixed-citation xml:lang="en">Haddy FJ. Role of dietary salt in hypertension. Life Sci 2006;79:1585-1592.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Orlov SN, Hamet P / The death of cardiotonic steroid-treated cells: evidence of Na+i,K+i-independent H+i-sensitive signalling. Acta Physiol (Oxf) 2006;187:231-240.</mixed-citation><mixed-citation xml:lang="en">Orlov SN, Hamet P / The death of cardiotonic steroid-treated cells: evidence of Na+i,K+i-independent H+i-sensitive signalling. Acta Physiol (Oxf) 2006;187:231-240.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Pierre SV. Xie Z. The Na,K-ATPase receptor complex: its organization and membership. Cell Biochem Biophys 2006;46(3):303-316.</mixed-citation><mixed-citation xml:lang="en">Pierre SV. Xie Z. The Na,K-ATPase receptor complex: its organization and membership. Cell Biochem Biophys 2006;46(3):303-316.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Nesher M, Shpolansky U, Rosen H, Lichtstein D. The digitalis-like steroid hormones: new mechanisms of action and biological significance. Life Sci 2007;80:2093-2107.</mixed-citation><mixed-citation xml:lang="en">Nesher M, Shpolansky U, Rosen H, Lichtstein D. The digitalis-like steroid hormones: new mechanisms of action and biological significance. Life Sci 2007;80:2093-2107.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Wasserstrom JA, Aistrup GL. Digitalis: new actions for an old drug. Am J Physiol Heart Circ Physiol 2005;289:H1781-H1793.</mixed-citation><mixed-citation xml:lang="en">Wasserstrom JA, Aistrup GL. Digitalis: new actions for an old drug. Am J Physiol Heart Circ Physiol 2005;289:H1781-H1793.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Huang BS, Amin MS, Leenen FH. The central role of the brain in salt-sensitive hypertension. Curr Opin Cardiol 2006;21:295-304</mixed-citation><mixed-citation xml:lang="en">Huang BS, Amin MS, Leenen FH. The central role of the brain in salt-sensitive hypertension. Curr Opin Cardiol 2006;21:295-304</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Blaustein MP, Zhang J, Chen L, Hamilton BP. How does salt retention raise blood pressure? Am J Physiol Regul Integr Comp Physiol 2006;290(3):R514-R523. '</mixed-citation><mixed-citation xml:lang="en">Blaustein MP, Zhang J, Chen L, Hamilton BP. How does salt retention raise blood pressure? Am J Physiol Regul Integr Comp Physiol 2006;290(3):R514-R523. '</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Schrier RW, Berl T. Nonosmolar factors affecting renal water excretion (first of two parts). N Engl J Med 1975;292:81-88.</mixed-citation><mixed-citation xml:lang="en">Schrier RW, Berl T. Nonosmolar factors affecting renal water excretion (first of two parts). N Engl J Med 1975;292:81-88.</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Schrier RW. Body fluid volume regulation in health and disease: a unifying hypothesis. Ann Intern Med 1990;113: 155-159.</mixed-citation><mixed-citation xml:lang="en">Schrier RW. Body fluid volume regulation in health and disease: a unifying hypothesis. Ann Intern Med 1990;113: 155-159.</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">De Wardener HE, Mills IH, Clapham WF, Hayter CJ. Studies on the efferent mechanism of the sodium diuresis which follows the administration of intravenous saline in the dog. Clin Sci 1961;21:249-258.</mixed-citation><mixed-citation xml:lang="en">De Wardener HE, Mills IH, Clapham WF, Hayter CJ. Studies on the efferent mechanism of the sodium diuresis which follows the administration of intravenous saline in the dog. Clin Sci 1961;21:249-258.</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Cort JH, Lichardus B. The natriuretic activity of jugular vein blood during carotid occlusion. Physiol Bohemoslov 1963;12:497-501.</mixed-citation><mixed-citation xml:lang="en">Cort JH, Lichardus B. The natriuretic activity of jugular vein blood during carotid occlusion. Physiol Bohemoslov 1963;12:497-501.</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Buckalew VM Jr, Martinez FJ, Green WE. The effect of dialysates and ultrafiltrates of plasma of saline-loaded dogs on toad bladder sodium transport. J Clin Invest 1970;49(5):926-935.</mixed-citation><mixed-citation xml:lang="en">Buckalew VM Jr, Martinez FJ, Green WE. The effect of dialysates and ultrafiltrates of plasma of saline-loaded dogs on toad bladder sodium transport. J Clin Invest 1970;49(5):926-935.</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Schrier RW, McDonald KM, Marshall RA, Lauler DP. Absence of natriuretic response to acute hypotonic intravascular volume expansion in dogs. Clin Sci 1968;34(1):57-72.</mixed-citation><mixed-citation xml:lang="en">Schrier RW, McDonald KM, Marshall RA, Lauler DP. Absence of natriuretic response to acute hypotonic intravascular volume expansion in dogs. Clin Sci 1968;34(1):57-72.</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Schrier RW, Verroust PJ, Jones JJ, Fabian M, Eee J, De Wardener HE. Effect of isotonic saline infusion and acute haemorrhage on plasma oxytocin and vasopressin concentrations in dogs. Clin Sci 1968;35:433-443</mixed-citation><mixed-citation xml:lang="en">Schrier RW, Verroust PJ, Jones JJ, Fabian M, Eee J, De Wardener HE. Effect of isotonic saline infusion and acute haemorrhage on plasma oxytocin and vasopressin concentrations in dogs. Clin Sci 1968;35:433-443</mixed-citation></citation-alternatives></ref><ref id="cit60"><label>60</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit61"><label>61</label><citation-alternatives><mixed-citation xml:lang="ru">de Wardener HE, Clarkson EM, Nutbourne DM, Schrier RW, Talner LB, Ventom MG, Verroust PJ. Evidence for a hormone other than aldosterone which controls urinary sodium excretion. Adv Nephrol Necker Hosp 1971;1:97-111</mixed-citation><mixed-citation xml:lang="en">de Wardener HE, Clarkson EM, Nutbourne DM, Schrier RW, Talner LB, Ventom MG, Verroust PJ. Evidence for a hormone other than aldosterone which controls urinary sodium excretion. Adv Nephrol Necker Hosp 1971;1:97-111</mixed-citation></citation-alternatives></ref><ref id="cit62"><label>62</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit63"><label>63</label><citation-alternatives><mixed-citation xml:lang="ru">Kramer HJ, Gonick HC. Effect of extracellular volume expansion on renal Na-K-ATPase and cell metabolism. Nephron 1974;12:281-296.</mixed-citation><mixed-citation xml:lang="en">Kramer HJ, Gonick HC. Effect of extracellular volume expansion on renal Na-K-ATPase and cell metabolism. Nephron 1974;12:281-296.</mixed-citation></citation-alternatives></ref><ref id="cit64"><label>64</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit65"><label>65</label><citation-alternatives><mixed-citation xml:lang="ru">Kaplan MA, Bourgoignie JJ. Rosecan J, Bricker NS. The effects of the natriuretic factor from uremic urine on sodium transport, water and electrolyte content, and pyruvate oxidation by the isolated toad bladder. J Clin Invest 1974;53(6):1568-1577.</mixed-citation><mixed-citation xml:lang="en">Kaplan MA, Bourgoignie JJ. Rosecan J, Bricker NS. The effects of the natriuretic factor from uremic urine on sodium transport, water and electrolyte content, and pyruvate oxidation by the isolated toad bladder. J Clin Invest 1974;53(6):1568-1577.</mixed-citation></citation-alternatives></ref><ref id="cit66"><label>66</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit67"><label>67</label><citation-alternatives><mixed-citation xml:lang="ru">Bricker NS, Schmidt RW, Favre H, Fine L, Bourgoignie JJ. On the biology of sodium excretion: the search for a natriuretic hormone. Yale J Biol Med 1975;48(4):293-303.</mixed-citation><mixed-citation xml:lang="en">Bricker NS, Schmidt RW, Favre H, Fine L, Bourgoignie JJ. On the biology of sodium excretion: the search for a natriuretic hormone. Yale J Biol Med 1975;48(4):293-303.</mixed-citation></citation-alternatives></ref><ref id="cit68"><label>68</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit69"><label>69</label><citation-alternatives><mixed-citation xml:lang="ru">Gruber KA, Whitaker JM, Buckalew VM Jr. Endogenous digitalis-like substance in plasma of volume-expanded dogs. Nature 1980;287(5784):743-745.</mixed-citation><mixed-citation xml:lang="en">Gruber KA, Whitaker JM, Buckalew VM Jr. Endogenous digitalis-like substance in plasma of volume-expanded dogs. Nature 1980;287(5784):743-745.</mixed-citation></citation-alternatives></ref><ref id="cit70"><label>70</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit71"><label>71</label><citation-alternatives><mixed-citation xml:lang="ru">Hamlyn JM, Ringel R, Schaeffer J, Levinson PD, Hamilton BP, Kowarski AA, Blaustein MP. A circulating inhibitor of (Na+ + K+)ATPase associated with essential hypertension. Nature 1982;300(5893):650-652.</mixed-citation><mixed-citation xml:lang="en">Hamlyn JM, Ringel R, Schaeffer J, Levinson PD, Hamilton BP, Kowarski AA, Blaustein MP. A circulating inhibitor of (Na+ + K+)ATPase associated with essential hypertension. Nature 1982;300(5893):650-652.</mixed-citation></citation-alternatives></ref><ref id="cit72"><label>72</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit73"><label>73</label><citation-alternatives><mixed-citation xml:lang="ru">Kojima I, Yoshihara S, Ogata E. Involvement of endogenous digitalis-like substance in genesis of deoxycorticosterone-salt hypertension. Life Sci 1982;30(21):1775-1781.</mixed-citation><mixed-citation xml:lang="en">Kojima I, Yoshihara S, Ogata E. Involvement of endogenous digitalis-like substance in genesis of deoxycorticosterone-salt hypertension. Life Sci 1982;30(21):1775-1781.</mixed-citation></citation-alternatives></ref><ref id="cit74"><label>74</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit75"><label>75</label><citation-alternatives><mixed-citation xml:lang="ru">Goto A, Yamada K, Yagi N, Yoshioka M, Sugimoto T. Physiology and pharmacology of endogenous digitalis-like factors. Pharmacol Rev 1992;44(3):377-399.</mixed-citation><mixed-citation xml:lang="en">Goto A, Yamada K, Yagi N, Yoshioka M, Sugimoto T. Physiology and pharmacology of endogenous digitalis-like factors. Pharmacol Rev 1992;44(3):377-399.</mixed-citation></citation-alternatives></ref><ref id="cit76"><label>76</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit77"><label>77</label><citation-alternatives><mixed-citation xml:lang="ru">Bergdдhl B, Molin L. Precision of digoxin radioimmunoassays and matrix effects: four kits compared. Clin Biochem 1981;14(2):67-71.</mixed-citation><mixed-citation xml:lang="en">Bergdдhl B, Molin L. Precision of digoxin radioimmunoassays and matrix effects: four kits compared. Clin Biochem 1981;14(2):67-71.</mixed-citation></citation-alternatives></ref><ref id="cit78"><label>78</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit79"><label>79</label><citation-alternatives><mixed-citation xml:lang="ru">Pleasants RA, Gadsden RH Sr, McCormack JP, Piveral K, Sawyer WT. Interference of digoxin-like immunoreactive substances with three digoxin immunoassays in patients with various degrees of renal function. Clin Pharm 1986;5(10): 810-816.</mixed-citation><mixed-citation xml:lang="en">Pleasants RA, Gadsden RH Sr, McCormack JP, Piveral K, Sawyer WT. Interference of digoxin-like immunoreactive substances with three digoxin immunoassays in patients with various degrees of renal function. Clin Pharm 1986;5(10): 810-816.</mixed-citation></citation-alternatives></ref><ref id="cit80"><label>80</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit81"><label>81</label><citation-alternatives><mixed-citation xml:lang="ru">Hauptman PJ, Kelly RA. Digitalis. Circulation 1999;99:1265-1270.</mixed-citation><mixed-citation xml:lang="en">Hauptman PJ, Kelly RA. Digitalis. Circulation 1999;99:1265-1270.</mixed-citation></citation-alternatives></ref><ref id="cit82"><label>82</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit83"><label>83</label><citation-alternatives><mixed-citation xml:lang="ru">Schneider R, Wray V, Nimtz M, Lehmann WD, Kirch U, Antolovic R, Schoner W. Bovine adrenals contain, in addition to ouabain, a second inhibitor of the sodium pump. J Biol Chem 1998;273(2):784-792.</mixed-citation><mixed-citation xml:lang="en">Schneider R, Wray V, Nimtz M, Lehmann WD, Kirch U, Antolovic R, Schoner W. Bovine adrenals contain, in addition to ouabain, a second inhibitor of the sodium pump. J Biol Chem 1998;273(2):784-792.</mixed-citation></citation-alternatives></ref><ref id="cit84"><label>84</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit85"><label>85</label><citation-alternatives><mixed-citation xml:lang="ru">Kawamura A, Guo J, Itagaki Y, Bell C, Wang Y, Haupert GT Jr et al. On the structure of endogenous ouabain. Proc Natl Acad Sci USA 1999;96(12):6654-6659.</mixed-citation><mixed-citation xml:lang="en">Kawamura A, Guo J, Itagaki Y, Bell C, Wang Y, Haupert GT Jr et al. On the structure of endogenous ouabain. Proc Natl Acad Sci USA 1999;96(12):6654-6659.</mixed-citation></citation-alternatives></ref><ref id="cit86"><label>86</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit87"><label>87</label><citation-alternatives><mixed-citation xml:lang="ru">Xie Z, Askari A. Na(+)/K(+)-ATPase as a signal transducer. Eur J Biochem 2002;269(10):2434-2439.</mixed-citation><mixed-citation xml:lang="en">Xie Z, Askari A. Na(+)/K(+)-ATPase as a signal transducer. Eur J Biochem 2002;269(10):2434-2439.</mixed-citation></citation-alternatives></ref><ref id="cit88"><label>88</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit89"><label>89</label><citation-alternatives><mixed-citation xml:lang="ru">Liu L, Mohammadi K, Aynafshar B, Wang H, Li D, Liu J et al. Role of caveolae in signal transducing function of cardiac Na+/K+-ATPase. Am J Physiol Cell Physiol 2003;284(6): C1550-C1560.</mixed-citation><mixed-citation xml:lang="en">Liu L, Mohammadi K, Aynafshar B, Wang H, Li D, Liu J et al. Role of caveolae in signal transducing function of cardiac Na+/K+-ATPase. Am J Physiol Cell Physiol 2003;284(6): C1550-C1560.</mixed-citation></citation-alternatives></ref><ref id="cit90"><label>90</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit91"><label>91</label><citation-alternatives><mixed-citation xml:lang="ru">Wang H, Haas M, Liang M, Cai T, Tian J, Li S, Xie Z. Ouabain assembles signaling cascades through the caveolar Na+/ K+-ATPase. J Biol Chem 2004;279(17):17250-17259.</mixed-citation><mixed-citation xml:lang="en">Wang H, Haas M, Liang M, Cai T, Tian J, Li S, Xie Z. Ouabain assembles signaling cascades through the caveolar Na+/ K+-ATPase. J Biol Chem 2004;279(17):17250-17259.</mixed-citation></citation-alternatives></ref><ref id="cit92"><label>92</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit93"><label>93</label><citation-alternatives><mixed-citation xml:lang="ru">Liang M, Tian J, Liu L, Pierre S, Liu J, Shapiro J, Xie ZJ. Identification of a pool of nonpumping Na/K-ATPase. J Biol Chem 2007;282(14):10585-10593.</mixed-citation><mixed-citation xml:lang="en">Liang M, Tian J, Liu L, Pierre S, Liu J, Shapiro J, Xie ZJ. Identification of a pool of nonpumping Na/K-ATPase. J Biol Chem 2007;282(14):10585-10593.</mixed-citation></citation-alternatives></ref><ref id="cit94"><label>94</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit95"><label>95</label><citation-alternatives><mixed-citation xml:lang="ru">Manunta P, Messaggio E, Ballabeni C, Sciarrone MT, Lanzani C, Ferrandi M et al. Plasma ouabain-like factor during acute and chronic changes in sodium balance in essential hypertension. Hypertension 2001;38(2):198-203.</mixed-citation><mixed-citation xml:lang="en">Manunta P, Messaggio E, Ballabeni C, Sciarrone MT, Lanzani C, Ferrandi M et al. Plasma ouabain-like factor during acute and chronic changes in sodium balance in essential hypertension. Hypertension 2001;38(2):198-203.</mixed-citation></citation-alternatives></ref><ref id="cit96"><label>96</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit97"><label>97</label><citation-alternatives><mixed-citation xml:lang="ru">Balzan S, Nicolini G, Iervasi A, Di Cecco P, Fommei E. Endogenous ouabain and acute salt loading in low-renin hypertension. Am J Hypertens 2005;18(7):906-909.</mixed-citation><mixed-citation xml:lang="en">Balzan S, Nicolini G, Iervasi A, Di Cecco P, Fommei E. Endogenous ouabain and acute salt loading in low-renin hypertension. Am J Hypertens 2005;18(7):906-909.</mixed-citation></citation-alternatives></ref><ref id="cit98"><label>98</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit99"><label>99</label><citation-alternatives><mixed-citation xml:lang="ru">Manunta P, Hamilton BP, Hamlyn JM. Salt intake and depletion increase circulating levels of endogenous ouabain in normal men. Am J Physiol Regul Integr Comp Physiol 2006;290(3): R553-R559.</mixed-citation><mixed-citation xml:lang="en">Manunta P, Hamilton BP, Hamlyn JM. Salt intake and depletion increase circulating levels of endogenous ouabain in normal men. Am J Physiol Regul Integr Comp Physiol 2006;290(3): R553-R559.</mixed-citation></citation-alternatives></ref><ref id="cit100"><label>100</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit101"><label>101</label><citation-alternatives><mixed-citation xml:lang="ru">Bagrov AY, Fedorova OV, Austin-Lane JL, Dmitrieva RI, Anderson DE. Endogenous marinobufagenin-like immunoreactive factor and Na,K-ATPase inhibition during voluntary hypoventilation. Hypertension 1995;26(5):781-788.</mixed-citation><mixed-citation xml:lang="en">Bagrov AY, Fedorova OV, Austin-Lane JL, Dmitrieva RI, Anderson DE. Endogenous marinobufagenin-like immunoreactive factor and Na,K-ATPase inhibition during voluntary hypoventilation. Hypertension 1995;26(5):781-788.</mixed-citation></citation-alternatives></ref><ref id="cit102"><label>102</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit103"><label>103</label><citation-alternatives><mixed-citation xml:lang="ru">Lopatin DA, Ailamazian EK, Dmitrieva RI, Shpen VM, Fedorova OV, Doris PA. Bagrov AY. Circulating bufodienolide and cardenolide sodium pump inhibitors in preeclampsia. J Hypertens 1999;17(8):1179-1187</mixed-citation><mixed-citation xml:lang="en">Lopatin DA, Ailamazian EK, Dmitrieva RI, Shpen VM, Fedorova OV, Doris PA. Bagrov AY. Circulating bufodienolide and cardenolide sodium pump inhibitors in preeclampsia. J Hypertens 1999;17(8):1179-1187</mixed-citation></citation-alternatives></ref><ref id="cit104"><label>104</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit105"><label>105</label><citation-alternatives><mixed-citation xml:lang="ru">Gonick HC, Ding Y, Vaziri ND, Bagrov AY, Fedorova OV. Simultaneous measurement of marinobufagenin, ouabain and hypertension associated protein in various disease states. Clin Exp Hypertens 1998;20(5-6):617-627.</mixed-citation><mixed-citation xml:lang="en">Gonick HC, Ding Y, Vaziri ND, Bagrov AY, Fedorova OV. Simultaneous measurement of marinobufagenin, ouabain and hypertension associated protein in various disease states. Clin Exp Hypertens 1998;20(5-6):617-627.</mixed-citation></citation-alternatives></ref><ref id="cit106"><label>106</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit107"><label>107</label><citation-alternatives><mixed-citation xml:lang="ru">Fridman AI, Matveev SA, Agalakova NI, Fedorova OV, Lakatta EG, Bagrov AY. Marinobufagenin, an endogenous ligand of alpha-1 Na/K-ATPase, is a marker of congestive heart failure severity. J Hypertens 2002;20(6): 1189-1194.</mixed-citation><mixed-citation xml:lang="en">Fridman AI, Matveev SA, Agalakova NI, Fedorova OV, Lakatta EG, Bagrov AY. Marinobufagenin, an endogenous ligand of alpha-1 Na/K-ATPase, is a marker of congestive heart failure severity. J Hypertens 2002;20(6): 1189-1194.</mixed-citation></citation-alternatives></ref><ref id="cit108"><label>108</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit109"><label>109</label><citation-alternatives><mixed-citation xml:lang="ru">Komiyama Y, Nishimura N, Munakata M, Mori T, Okuda K, Nishino N et al. Identification of endogenous ouabain in culture supernatant of PC12 cells. J Hypertens 2001;19(2):229-236.</mixed-citation><mixed-citation xml:lang="en">Komiyama Y, Nishimura N, Munakata M, Mori T, Okuda K, Nishino N et al. Identification of endogenous ouabain in culture supernatant of PC12 cells. J Hypertens 2001;19(2):229-236.</mixed-citation></citation-alternatives></ref><ref id="cit110"><label>110</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit111"><label>111</label><citation-alternatives><mixed-citation xml:lang="ru">Murrell JR, Randall JD, Rosoff J, Zhao JL, Jensen RV, Gullans SR, Haupert GT Jr. Endogenous ouabain: upregulation of steroidogenic genes in hypertensive hypothalamus but not adrenal. Circulation 2005;112(9):1301- 1308.</mixed-citation><mixed-citation xml:lang="en">Murrell JR, Randall JD, Rosoff J, Zhao JL, Jensen RV, Gullans SR, Haupert GT Jr. Endogenous ouabain: upregulation of steroidogenic genes in hypertensive hypothalamus but not adrenal. Circulation 2005;112(9):1301- 1308.</mixed-citation></citation-alternatives></ref><ref id="cit112"><label>112</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit113"><label>113</label><citation-alternatives><mixed-citation xml:lang="ru">el-Masri MA, Clark BJ, Qazzaz HM, Valdes R Jr. Human adrenal cells in culture produce both ouabain-like and dihydroouabain-like factors. Clin Chem 2002;48(10):1720-1730.</mixed-citation><mixed-citation xml:lang="en">el-Masri MA, Clark BJ, Qazzaz HM, Valdes R Jr. Human adrenal cells in culture produce both ouabain-like and dihydroouabain-like factors. Clin Chem 2002;48(10):1720-1730.</mixed-citation></citation-alternatives></ref><ref id="cit114"><label>114</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit115"><label>115</label><citation-alternatives><mixed-citation xml:lang="ru">Laredo J, Shah JR, Lu ZR, Hamilton BP, Hamlyn JM. Angiotensin II stimulates secretion of endogenous ouabain from bovine adrenocortical cells via angiotensin type 2 receptors. Hypertension 1997;29(1 Pt 2):401-407.</mixed-citation><mixed-citation xml:lang="en">Laredo J, Shah JR, Lu ZR, Hamilton BP, Hamlyn JM. Angiotensin II stimulates secretion of endogenous ouabain from bovine adrenocortical cells via angiotensin type 2 receptors. Hypertension 1997;29(1 Pt 2):401-407.</mixed-citation></citation-alternatives></ref><ref id="cit116"><label>116</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit117"><label>117</label><citation-alternatives><mixed-citation xml:lang="ru">Shah JR, Laredo J, Hamilton BP, Hamlyn JM. Effects of angiotensin II on sodium potassium pumps, endogenous ouabain, and aldosterone in bovine zona glomerulosa cells. Hypertension 1999;33(1 Pt 2):373-377.</mixed-citation><mixed-citation xml:lang="en">Shah JR, Laredo J, Hamilton BP, Hamlyn JM. Effects of angiotensin II on sodium potassium pumps, endogenous ouabain, and aldosterone in bovine zona glomerulosa cells. Hypertension 1999;33(1 Pt 2):373-377.</mixed-citation></citation-alternatives></ref><ref id="cit118"><label>118</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit119"><label>119</label><citation-alternatives><mixed-citation xml:lang="ru">Goto A, Ishiguro T, Yamada K, Ishii M, Yoshioka M, Eguchi С et al. Isolation of a urinary digitalislike factor indistinguishable from digoxin. Biochem Biophys Res Commun 1990;173(3):1093-1101.</mixed-citation><mixed-citation xml:lang="en">Goto A, Ishiguro T, Yamada K, Ishii M, Yoshioka M, Eguchi С et al. Isolation of a urinary digitalislike factor indistinguishable from digoxin. Biochem Biophys Res Commun 1990;173(3):1093-1101.</mixed-citation></citation-alternatives></ref><ref id="cit120"><label>120</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit121"><label>121</label><citation-alternatives><mixed-citation xml:lang="ru">Qazzaz HM, Goudy SL, Valdes R Jr. Deglycosylated products of endogenous digoxin-like immunoreactive factor in mammalian tissue. J Biol Chem 1996;271(15):8731-8737.</mixed-citation><mixed-citation xml:lang="en">Qazzaz HM, Goudy SL, Valdes R Jr. Deglycosylated products of endogenous digoxin-like immunoreactive factor in mammalian tissue. J Biol Chem 1996;271(15):8731-8737.</mixed-citation></citation-alternatives></ref><ref id="cit122"><label>122</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit123"><label>123</label><citation-alternatives><mixed-citation xml:lang="ru">Huang BS, Kudlac M, Kumarathasan R, Leenen FH. Digoxin prevents ouabain and high salt intake-induced hypertension in rats with sinoaortic denervation. Hypertension 1999;34(4 Pt 2):733-738.</mixed-citation><mixed-citation xml:lang="en">Huang BS, Kudlac M, Kumarathasan R, Leenen FH. Digoxin prevents ouabain and high salt intake-induced hypertension in rats with sinoaortic denervation. Hypertension 1999;34(4 Pt 2):733-738.</mixed-citation></citation-alternatives></ref><ref id="cit124"><label>124</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit125"><label>125</label><citation-alternatives><mixed-citation xml:lang="ru">Goto A, Yamada K, Yagi N, Hui C, Sugimoto T. Digoxin-like immunoreactivity: is it still worth measuring? Life Sci 1991;49(23):1667-1678.</mixed-citation><mixed-citation xml:lang="en">Goto A, Yamada K, Yagi N, Hui C, Sugimoto T. Digoxin-like immunoreactivity: is it still worth measuring? Life Sci 1991;49(23):1667-1678.</mixed-citation></citation-alternatives></ref><ref id="cit126"><label>126</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit127"><label>127</label><citation-alternatives><mixed-citation xml:lang="ru">Meyer К and Linde H. Collection of toad venoms and chemistry of the toad venom steroids. In Venomous animals and their venoms, 521-556 (Eds Bucherl W and Buckley E) London: Academic Press 1971.</mixed-citation><mixed-citation xml:lang="en">Meyer К and Linde H. Collection of toad venoms and chemistry of the toad venom steroids. In Venomous animals and their venoms, 521-556 (Eds Bucherl W and Buckley E) London: Academic Press 1971.</mixed-citation></citation-alternatives></ref><ref id="cit128"><label>128</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit129"><label>129</label><citation-alternatives><mixed-citation xml:lang="ru">Chen KK, Kowarikowa A. Pharmacology and toxicology of toad venom. J Pharmacol Sci 1967;56:1535-1542.</mixed-citation><mixed-citation xml:lang="en">Chen KK, Kowarikowa A. Pharmacology and toxicology of toad venom. J Pharmacol Sci 1967;56:1535-1542.</mixed-citation></citation-alternatives></ref><ref id="cit130"><label>130</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit131"><label>131</label><citation-alternatives><mixed-citation xml:lang="ru">Flier J, Edwards MW, Daly JW, Myers CW. Widespread occurrence in frogs and toads of skin compounds interacting with the ouabain site of Na+,K+-ATPase. Science 1980;208(4443):503-505.</mixed-citation><mixed-citation xml:lang="en">Flier J, Edwards MW, Daly JW, Myers CW. Widespread occurrence in frogs and toads of skin compounds interacting with the ouabain site of Na+,K+-ATPase. Science 1980;208(4443):503-505.</mixed-citation></citation-alternatives></ref><ref id="cit132"><label>132</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit133"><label>133</label><citation-alternatives><mixed-citation xml:lang="ru">Lichtstein D, Gati I, Babila T, Haver E, Katz U. Effect of salt acclimation on digitalis-like compounds in the toad. Biochim Biophys Acta 1991;1073(l):65-68.</mixed-citation><mixed-citation xml:lang="en">Lichtstein D, Gati I, Babila T, Haver E, Katz U. Effect of salt acclimation on digitalis-like compounds in the toad. Biochim Biophys Acta 1991;1073(l):65-68.</mixed-citation></citation-alternatives></ref><ref id="cit134"><label>134</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit135"><label>135</label><citation-alternatives><mixed-citation xml:lang="ru">Kieval RS, Butler VP Jr, Derguini F, Bruening RC, Rosen MR. Cellular electrophysiologic effects of vertebrate digitalis-like substances.J Am Col Cardiol 1988;11(3):637-643.</mixed-citation><mixed-citation xml:lang="en">Kieval RS, Butler VP Jr, Derguini F, Bruening RC, Rosen MR. Cellular electrophysiologic effects of vertebrate digitalis-like substances.J Am Col Cardiol 1988;11(3):637-643.</mixed-citation></citation-alternatives></ref><ref id="cit136"><label>136</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit137"><label>137</label><citation-alternatives><mixed-citation xml:lang="ru">Goto A, Yamada K, Ishii M, Sugimoto T, Yoshioka M. Immunoreactivity of endogenous digitalis-like factors. Biochem Pharmacol 1991;41(8):1261-1263.</mixed-citation><mixed-citation xml:lang="en">Goto A, Yamada K, Ishii M, Sugimoto T, Yoshioka M. Immunoreactivity of endogenous digitalis-like factors. Biochem Pharmacol 1991;41(8):1261-1263.</mixed-citation></citation-alternatives></ref><ref id="cit138"><label>138</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit139"><label>139</label><citation-alternatives><mixed-citation xml:lang="ru">Numazawa S, Honma Y, Yamamoto T, Yoshida T, Kuroiwa Y. A cardiotonic steroid bufalin-like factor in human plasma induces leukemia cell differentiation. Leuk Res 1995;19(12):945-953.</mixed-citation><mixed-citation xml:lang="en">Numazawa S, Honma Y, Yamamoto T, Yoshida T, Kuroiwa Y. A cardiotonic steroid bufalin-like factor in human plasma induces leukemia cell differentiation. Leuk Res 1995;19(12):945-953.</mixed-citation></citation-alternatives></ref><ref id="cit140"><label>140</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit141"><label>141</label><citation-alternatives><mixed-citation xml:lang="ru">Oda M, Kurosawa M, Numazawa S, Tanaka S, Akizawa T, Ito К et al. Determination of bufalin-like immunoreactivity in serum of humans and rats by time-resolved fluoroimmunoassay for using a monoclonal antibody. Life Sci 2001;68(10): 1107-1117.</mixed-citation><mixed-citation xml:lang="en">Oda M, Kurosawa M, Numazawa S, Tanaka S, Akizawa T, Ito К et al. Determination of bufalin-like immunoreactivity in serum of humans and rats by time-resolved fluoroimmunoassay for using a monoclonal antibody. Life Sci 2001;68(10): 1107-1117.</mixed-citation></citation-alternatives></ref><ref id="cit142"><label>142</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit143"><label>143</label><citation-alternatives><mixed-citation xml:lang="ru">Sich B, Kirch U, Tepel M, Zidek W, Schoner W. Pulse pressure correlates in humans with a proscillaridin A immunoreactive compound. Hypertension 1996;27(5):1073-1078.</mixed-citation><mixed-citation xml:lang="en">Sich B, Kirch U, Tepel M, Zidek W, Schoner W. Pulse pressure correlates in humans with a proscillaridin A immunoreactive compound. Hypertension 1996;27(5):1073-1078.</mixed-citation></citation-alternatives></ref><ref id="cit144"><label>144</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit145"><label>145</label><citation-alternatives><mixed-citation xml:lang="ru">Hilton PJ, White RW, Lord GA, Garner GV, Gordon DB, Hilton MJ et al. An inhibitor of the sodium pump obtained from human placenta. Lancet 1996;348(9023):303-305.</mixed-citation><mixed-citation xml:lang="en">Hilton PJ, White RW, Lord GA, Garner GV, Gordon DB, Hilton MJ et al. An inhibitor of the sodium pump obtained from human placenta. Lancet 1996;348(9023):303-305.</mixed-citation></citation-alternatives></ref><ref id="cit146"><label>146</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit147"><label>147</label><citation-alternatives><mixed-citation xml:lang="ru">Bagrov AY, Roukoyatkina NI, Fedorova OV, Pinaev AG, Ukhanova MV. Digitalis-like and vasoconstrictor properties of endogenous digoxinlike factor from Bufo marinus toad. Eur J Pharmacol 1993;234(2-3):165-172.</mixed-citation><mixed-citation xml:lang="en">Bagrov AY, Roukoyatkina NI, Fedorova OV, Pinaev AG, Ukhanova MV. Digitalis-like and vasoconstrictor properties of endogenous digoxinlike factor from Bufo marinus toad. Eur J Pharmacol 1993;234(2-3):165-172.</mixed-citation></citation-alternatives></ref><ref id="cit148"><label>148</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit149"><label>149</label><citation-alternatives><mixed-citation xml:lang="ru">Bagrov AY, Roukoyatkina NI, Pinaev AG, Dmitrieva RI, Fedorova OV. Effects of two endogenous digitalis-like factors, ouabain and marinobufagenin in isolated rat aorta. Eur J Pharmacol 1995;274(1-3):151-158.</mixed-citation><mixed-citation xml:lang="en">Bagrov AY, Roukoyatkina NI, Pinaev AG, Dmitrieva RI, Fedorova OV. Effects of two endogenous digitalis-like factors, ouabain and marinobufagenin in isolated rat aorta. Eur J Pharmacol 1995;274(1-3):151-158.</mixed-citation></citation-alternatives></ref><ref id="cit150"><label>150</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit151"><label>151</label><citation-alternatives><mixed-citation xml:lang="ru">Bagrov AY, Dmitrieva RI, Fedorova OV, Kazakov GP, Roukoyatkina NI, Shpen VM. Endogenous marinobufagenin-like immunoreactive substance: a possible endogenous Na,K-ATPase inhibitor with vasoconstrictor activity. Am J Hypertens 1996;9(10 Pt 1):982-990</mixed-citation><mixed-citation xml:lang="en">Bagrov AY, Dmitrieva RI, Fedorova OV, Kazakov GP, Roukoyatkina NI, Shpen VM. Endogenous marinobufagenin-like immunoreactive substance: a possible endogenous Na,K-ATPase inhibitor with vasoconstrictor activity. Am J Hypertens 1996;9(10 Pt 1):982-990</mixed-citation></citation-alternatives></ref><ref id="cit152"><label>152</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit153"><label>153</label><citation-alternatives><mixed-citation xml:lang="ru">Ho CS, Butt A, Semra YK, Swaminathan R. Effect of carbidopa on the excretion of sodium, dopamine, and ouabain-like substance in the rat. Hypertension 1997;30(6):1544-1548.</mixed-citation><mixed-citation xml:lang="en">Ho CS, Butt A, Semra YK, Swaminathan R. Effect of carbidopa on the excretion of sodium, dopamine, and ouabain-like substance in the rat. Hypertension 1997;30(6):1544-1548.</mixed-citation></citation-alternatives></ref><ref id="cit154"><label>154</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit155"><label>155</label><citation-alternatives><mixed-citation xml:lang="ru">Butt AN, Semra YK, Ho CS, Swaminathan R. Effect of high salt intake on plasma and tissue concentration of endogenous ouabain-like substance in the rat. Life Sci 1997;61(24):2367-7233.</mixed-citation><mixed-citation xml:lang="en">Butt AN, Semra YK, Ho CS, Swaminathan R. Effect of high salt intake on plasma and tissue concentration of endogenous ouabain-like substance in the rat. Life Sci 1997;61(24):2367-7233.</mixed-citation></citation-alternatives></ref><ref id="cit156"><label>156</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit157"><label>157</label><citation-alternatives><mixed-citation xml:lang="ru">Ludens JH, Clark MA, Kolbasa KP, Hamlyn JM. Digitalis-like factor and ouabain-like compound in plasma of volume expanded dogs. J Cardiovasc Pharmacol 1993;22 (Suppl 2):S38-S41.</mixed-citation><mixed-citation xml:lang="en">Ludens JH, Clark MA, Kolbasa KP, Hamlyn JM. Digitalis-like factor and ouabain-like compound in plasma of volume expanded dogs. J Cardiovasc Pharmacol 1993;22 (Suppl 2):S38-S41.</mixed-citation></citation-alternatives></ref><ref id="cit158"><label>158</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit159"><label>159</label><citation-alternatives><mixed-citation xml:lang="ru">Bagrov AY, Fedorova OV, Dmitrieva RI, French AW, Anderson DE. Plasma marinobufagenin-like and ouabain-like immunorecativity during acute saline volume expansion in anesthetized dogs. Cardiovasc Res 1996;31(2):296-305.</mixed-citation><mixed-citation xml:lang="en">Bagrov AY, Fedorova OV, Dmitrieva RI, French AW, Anderson DE. Plasma marinobufagenin-like and ouabain-like immunorecativity during acute saline volume expansion in anesthetized dogs. Cardiovasc Res 1996;31(2):296-305.</mixed-citation></citation-alternatives></ref><ref id="cit160"><label>160</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit161"><label>161</label><citation-alternatives><mixed-citation xml:lang="ru">Fedorova OV et al. Interaction of high sodium chloride intake and psychosocial stress on endogenous ligands of the sodium pump and blood pressure in normotensive rats. Am J Physiol 2001;281:R352-R358.</mixed-citation><mixed-citation xml:lang="en">Fedorova OV et al. Interaction of high sodium chloride intake and psychosocial stress on endogenous ligands of the sodium pump and blood pressure in normotensive rats. Am J Physiol 2001;281:R352-R358.</mixed-citation></citation-alternatives></ref><ref id="cit162"><label>162</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit163"><label>163</label><citation-alternatives><mixed-citation xml:lang="ru">Fedorova OV et al. Differential effects of acute NaCl loading on endogenous ouabain-like and marinobufagenin-like ligands of the sodium pump in Dahl hypertensive rats. Circulation 2000;102:3009-3014</mixed-citation><mixed-citation xml:lang="en">Fedorova OV et al. Differential effects of acute NaCl loading on endogenous ouabain-like and marinobufagenin-like ligands of the sodium pump in Dahl hypertensive rats. Circulation 2000;102:3009-3014</mixed-citation></citation-alternatives></ref><ref id="cit164"><label>164</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit165"><label>165</label><citation-alternatives><mixed-citation xml:lang="ru">Fedorova OV, Talan MI, Agalakova NI, Lakatta EG, Bagrov AY. An endogenous ligand of б-1 sodium pump, marinobufagenin, is a novel mediator of sodium chloride dependent hypertension. Circulation 2002;105(9):1122-1127.</mixed-citation><mixed-citation xml:lang="en">Fedorova OV, Talan MI, Agalakova NI, Lakatta EG, Bagrov AY. An endogenous ligand of б-1 sodium pump, marinobufagenin, is a novel mediator of sodium chloride dependent hypertension. Circulation 2002;105(9):1122-1127.</mixed-citation></citation-alternatives></ref><ref id="cit166"><label>166</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit167"><label>167</label><citation-alternatives><mixed-citation xml:lang="ru">Anderson DE, Fedorova OV, Morrell CH, Longo DL, Kashkin VA, Metzler JD et al. Endogenous sodium pump inhibitors and age-associated increases in salt sensitivity of blood pressure in normotensivcs. Am J Physiol Regul Integr Comp Physiol 2008;294(4):R1248-R1254.</mixed-citation><mixed-citation xml:lang="en">Anderson DE, Fedorova OV, Morrell CH, Longo DL, Kashkin VA, Metzler JD et al. Endogenous sodium pump inhibitors and age-associated increases in salt sensitivity of blood pressure in normotensivcs. Am J Physiol Regul Integr Comp Physiol 2008;294(4):R1248-R1254.</mixed-citation></citation-alternatives></ref><ref id="cit168"><label>168</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit169"><label>169</label><citation-alternatives><mixed-citation xml:lang="ru">Ferrari P, Ferrandi M, Valentini G, Bianchi G. Rostafuroxin: an ouabain antagonist that corrects renal and vascular Na+-K+-ATPase alterations in ouabain and adducing dependent hypertension. Am J Physiol Regul Integr Comp Physiol 2006;290(3):R529-R535.</mixed-citation><mixed-citation xml:lang="en">Ferrari P, Ferrandi M, Valentini G, Bianchi G. Rostafuroxin: an ouabain antagonist that corrects renal and vascular Na+-K+-ATPase alterations in ouabain and adducing dependent hypertension. Am J Physiol Regul Integr Comp Physiol 2006;290(3):R529-R535.</mixed-citation></citation-alternatives></ref><ref id="cit170"><label>170</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit171"><label>171</label><citation-alternatives><mixed-citation xml:lang="ru">Rossoni LV, Salaices M, Miguel M, Briones AM, Barker LA, Vassallo DV, Alonso MJ. Ouabain-induced hypertension is accompanied by increases in endothelial vasodilator factors. Am J Physiol Heart Circ Physiol 2002;283(5):H2110-H2118</mixed-citation><mixed-citation xml:lang="en">Rossoni LV, Salaices M, Miguel M, Briones AM, Barker LA, Vassallo DV, Alonso MJ. Ouabain-induced hypertension is accompanied by increases in endothelial vasodilator factors. Am J Physiol Heart Circ Physiol 2002;283(5):H2110-H2118</mixed-citation></citation-alternatives></ref><ref id="cit172"><label>172</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit173"><label>173</label><citation-alternatives><mixed-citation xml:lang="ru">Ferrandi M, Molinari I, Barassi P, Minotti E, Bianchi G, Ferrari P. Organ hypertrophic signaling within caveolae membrane subdomains triggered by ouabain and antagonized by PST 2238. J Biol Chem 2004;279(32):33306-33314.</mixed-citation><mixed-citation xml:lang="en">Ferrandi M, Molinari I, Barassi P, Minotti E, Bianchi G, Ferrari P. Organ hypertrophic signaling within caveolae membrane subdomains triggered by ouabain and antagonized by PST 2238. J Biol Chem 2004;279(32):33306-33314.</mixed-citation></citation-alternatives></ref><ref id="cit174"><label>174</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit175"><label>175</label><citation-alternatives><mixed-citation xml:lang="ru">Dostanic-Larson I, Van Huysse JW, Lorenz JN, Lingrel JB. The highly conserved cardiac glycoside binding site of Na,K-ATPase plays a role in blood pressure regulation. Proc Natl Acad Sci USA 2005;102(44):15845-15850.</mixed-citation><mixed-citation xml:lang="en">Dostanic-Larson I, Van Huysse JW, Lorenz JN, Lingrel JB. The highly conserved cardiac glycoside binding site of Na,K-ATPase plays a role in blood pressure regulation. Proc Natl Acad Sci USA 2005;102(44):15845-15850.</mixed-citation></citation-alternatives></ref><ref id="cit176"><label>176</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit177"><label>177</label><citation-alternatives><mixed-citation xml:lang="ru">Briones AM, Xavier FE, Arribas SM, Gonzalez MC, Rossoni LV, Alonso MJ, Salaices M. Alterations in structure and mechanics of resistance arteries from ouabain induced hypertensive rats. Am J Physiol Heart Circ Physiol 2006;291(1):H193-H201.</mixed-citation><mixed-citation xml:lang="en">Briones AM, Xavier FE, Arribas SM, Gonzalez MC, Rossoni LV, Alonso MJ, Salaices M. Alterations in structure and mechanics of resistance arteries from ouabain induced hypertensive rats. Am J Physiol Heart Circ Physiol 2006;291(1):H193-H201.</mixed-citation></citation-alternatives></ref><ref id="cit178"><label>178</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit179"><label>179</label><citation-alternatives><mixed-citation xml:lang="ru">Cheung WJ, Kent MA, El-Shahat E, Wang H, Tan J, White R, Leenen FH. Central and peripheral renin-angiotensin systems in ouabain-induced hypertension. Am J Physiol Heart Circ Physiol 2006;291(2):H624-H630.</mixed-citation><mixed-citation xml:lang="en">Cheung WJ, Kent MA, El-Shahat E, Wang H, Tan J, White R, Leenen FH. Central and peripheral renin-angiotensin systems in ouabain-induced hypertension. Am J Physiol Heart Circ Physiol 2006;291(2):H624-H630.</mixed-citation></citation-alternatives></ref><ref id="cit180"><label>180</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit181"><label>181</label><citation-alternatives><mixed-citation xml:lang="ru">Rossoni LV, Xavier FE, Moreira CM, Falcochio D, Amanso AM, Tanoue CU et al. Ouabain-induced hypertension enhances left ventricular contractility in rats. Life Sci 2006;79(16):1537-1545.</mixed-citation><mixed-citation xml:lang="en">Rossoni LV, Xavier FE, Moreira CM, Falcochio D, Amanso AM, Tanoue CU et al. Ouabain-induced hypertension enhances left ventricular contractility in rats. Life Sci 2006;79(16):1537-1545.</mixed-citation></citation-alternatives></ref><ref id="cit182"><label>182</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit183"><label>183</label><citation-alternatives><mixed-citation xml:lang="ru">Bianchi G, Tripodi G, Casari G, Salardi S, Barber BR, Garcia R et al. Two point mutations within the adducin genes are involved in blood pressure variation. Proc Natl Acad Sci USA 1994;91(9):3999-4003.</mixed-citation><mixed-citation xml:lang="en">Bianchi G, Tripodi G, Casari G, Salardi S, Barber BR, Garcia R et al. Two point mutations within the adducin genes are involved in blood pressure variation. Proc Natl Acad Sci USA 1994;91(9):3999-4003.</mixed-citation></citation-alternatives></ref><ref id="cit184"><label>184</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit185"><label>185</label><citation-alternatives><mixed-citation xml:lang="ru">Efendiev R, Krmar RT, Ogimoto G, Zwiller J, Tripodi G, Katz AI et al. Hypertension-linked mutation in the adducin alpha-subunit leads to higher AP2-mu2 phosphorylation and impaired Na+K+-ATPase trafficking in response to GPCR signals and intracellular sodium. Circ Res 2004;95(11):1100-1108.</mixed-citation><mixed-citation xml:lang="en">Efendiev R, Krmar RT, Ogimoto G, Zwiller J, Tripodi G, Katz AI et al. Hypertension-linked mutation in the adducin alpha-subunit leads to higher AP2-mu2 phosphorylation and impaired Na+K+-ATPase trafficking in response to GPCR signals and intracellular sodium. Circ Res 2004;95(11):1100-1108.</mixed-citation></citation-alternatives></ref><ref id="cit186"><label>186</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit187"><label>187</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang J, Lee MY, Cavalli M, Chen L, Berra-Romani R, Balke CW et al. Sodium pump б2 subunits control myogenic tone and blood pressure in mice. J Physiol 2005;569(Pt l):243-256.</mixed-citation><mixed-citation xml:lang="en">Zhang J, Lee MY, Cavalli M, Chen L, Berra-Romani R, Balke CW et al. Sodium pump б2 subunits control myogenic tone and blood pressure in mice. J Physiol 2005;569(Pt l):243-256.</mixed-citation></citation-alternatives></ref><ref id="cit188"><label>188</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit189"><label>189</label><citation-alternatives><mixed-citation xml:lang="ru">Liu J, Kesiry R, Periyasamy SM, Malhotra D, Xie Z, Shapiro JI. Ouabain induces endocytosis of plasmalemmal Na/K-ATPase in LLC-PK1 cells by a clathrin-dependent mechanism. Kidney Int 2004;66(1):227-241.</mixed-citation><mixed-citation xml:lang="en">Liu J, Kesiry R, Periyasamy SM, Malhotra D, Xie Z, Shapiro JI. Ouabain induces endocytosis of plasmalemmal Na/K-ATPase in LLC-PK1 cells by a clathrin-dependent mechanism. Kidney Int 2004;66(1):227-241.</mixed-citation></citation-alternatives></ref><ref id="cit190"><label>190</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit191"><label>191</label><citation-alternatives><mixed-citation xml:lang="ru">Liu J, Liang M, Liu L, Malhotra D, Xie Z, Shapiro JI. Ouabain-induced endocytosis of the plasmalemmal Na/K- ATPase in LLC-PK1 cells requires caveolin-1. Kidney Int 2005;67(5): 1844-1854.</mixed-citation><mixed-citation xml:lang="en">Liu J, Liang M, Liu L, Malhotra D, Xie Z, Shapiro JI. Ouabain-induced endocytosis of the plasmalemmal Na/K- ATPase in LLC-PK1 cells requires caveolin-1. Kidney Int 2005;67(5): 1844-1854.</mixed-citation></citation-alternatives></ref><ref id="cit192"><label>192</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit193"><label>193</label><citation-alternatives><mixed-citation xml:lang="ru">Nguyen AN, Wallace DP, Blanco G. Ouabain binds with high affinity to the Na,K-ATPase in human polycystic kidney cells and induces extracellular signal regulated kinase activation and cell proliferation. J Am Soc Nephrol 2007;18(1):46-57.</mixed-citation><mixed-citation xml:lang="en">Nguyen AN, Wallace DP, Blanco G. Ouabain binds with high affinity to the Na,K-ATPase in human polycystic kidney cells and induces extracellular signal regulated kinase activation and cell proliferation. J Am Soc Nephrol 2007;18(1):46-57.</mixed-citation></citation-alternatives></ref><ref id="cit194"><label>194</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit195"><label>195</label><citation-alternatives><mixed-citation xml:lang="ru">Wang JG, Staessen JA, Messaggio E, Nawrot T, Fagard R, Hamlyn JM et al. Salt, endogenous ouabain and blood pressure interactions in the general population. J Hypertens 2003;21(8):1475-1481.</mixed-citation><mixed-citation xml:lang="en">Wang JG, Staessen JA, Messaggio E, Nawrot T, Fagard R, Hamlyn JM et al. Salt, endogenous ouabain and blood pressure interactions in the general population. J Hypertens 2003;21(8):1475-1481.</mixed-citation></citation-alternatives></ref><ref id="cit196"><label>196</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit197"><label>197</label><citation-alternatives><mixed-citation xml:lang="ru">Ferrari P, Ferrandi M, Tripodi G, Torielli L, Padoani G, Minotti E et al. PST 2238: a new antihypertensive compound that modulates Na,K ATPase in genetic hypertension. J Pharmacol Exp Ther 1999;288(3):1074-1083.</mixed-citation><mixed-citation xml:lang="en">Ferrari P, Ferrandi M, Tripodi G, Torielli L, Padoani G, Minotti E et al. PST 2238: a new antihypertensive compound that modulates Na,K ATPase in genetic hypertension. J Pharmacol Exp Ther 1999;288(3):1074-1083.</mixed-citation></citation-alternatives></ref><ref id="cit198"><label>198</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit199"><label>199</label><citation-alternatives><mixed-citation xml:lang="ru">Huang BS, Leenen FH. Brain 'ouabain' and angiotensin II in salt-sensitive hypertension in spontaneously hypertensive rats. Hypertension 1996:28:1005-1012.</mixed-citation><mixed-citation xml:lang="en">Huang BS, Leenen FH. Brain 'ouabain' and angiotensin II in salt-sensitive hypertension in spontaneously hypertensive rats. Hypertension 1996:28:1005-1012.</mixed-citation></citation-alternatives></ref><ref id="cit200"><label>200</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit201"><label>201</label><citation-alternatives><mixed-citation xml:lang="ru">Huang BS, Leenen FH. Both brain angiotensin II and 'ouabain' contribute to sympathocxcitation and hypertension in Dahl S rats on high salt intake. Hypertension 1998;32: 028-1033.</mixed-citation><mixed-citation xml:lang="en">Huang BS, Leenen FH. Both brain angiotensin II and 'ouabain' contribute to sympathocxcitation and hypertension in Dahl S rats on high salt intake. Hypertension 1998;32: 028-1033.</mixed-citation></citation-alternatives></ref><ref id="cit202"><label>202</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit203"><label>203</label><citation-alternatives><mixed-citation xml:lang="ru">Fedorova OV, Zhuravin IA, Agalakova NI, Yamova LA, Talan MI, Lakatta EG, Bagrov AY. Intrahippocampal microinjection of an exquisitely low dose of ouabain mimics NaCl loading and stimulates a bufadienolide Na/K-ATPase inhibitor. J Hypertens 2007;25(9):1834-1844.</mixed-citation><mixed-citation xml:lang="en">Fedorova OV, Zhuravin IA, Agalakova NI, Yamova LA, Talan MI, Lakatta EG, Bagrov AY. Intrahippocampal microinjection of an exquisitely low dose of ouabain mimics NaCl loading and stimulates a bufadienolide Na/K-ATPase inhibitor. J Hypertens 2007;25(9):1834-1844.</mixed-citation></citation-alternatives></ref><ref id="cit204"><label>204</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit205"><label>205</label><citation-alternatives><mixed-citation xml:lang="ru">Fedorova OV, Agalakova NI, Talan MI, Lakatta EG, Bagrov AY. Brain ouabain stimulates peripheral marinobufagenin via angiotensin II signalling in NaCl loaded Dahl-S rats. J Hypertens 2005;23(8):1515-1523.</mixed-citation><mixed-citation xml:lang="en">Fedorova OV, Agalakova NI, Talan MI, Lakatta EG, Bagrov AY. Brain ouabain stimulates peripheral marinobufagenin via angiotensin II signalling in NaCl loaded Dahl-S rats. J Hypertens 2005;23(8):1515-1523.</mixed-citation></citation-alternatives></ref><ref id="cit206"><label>206</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit207"><label>207</label><citation-alternatives><mixed-citation xml:lang="ru">Takahashi H, Iyoda I, Takeda K, Sasaki S, Okajima H, Yamasaki H, Yoshimura M, Ijichi H. Centrally-induced vasopressor responses to sodium-potassium adenosine triphosphatase inhibitor, ouabain, may be mediated via angiotensin II in the anteroventral third ventricle in the brain. Jpn Circ J 1984;48(11): 1243-1250.</mixed-citation><mixed-citation xml:lang="en">Takahashi H, Iyoda I, Takeda K, Sasaki S, Okajima H, Yamasaki H, Yoshimura M, Ijichi H. Centrally-induced vasopressor responses to sodium-potassium adenosine triphosphatase inhibitor, ouabain, may be mediated via angiotensin II in the anteroventral third ventricle in the brain. Jpn Circ J 1984;48(11): 1243-1250.</mixed-citation></citation-alternatives></ref><ref id="cit208"><label>208</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit209"><label>209</label><citation-alternatives><mixed-citation xml:lang="ru">Huang BS, Leenen FHH. Sympathoexcitatory and pressor responses to increased brain sodium and ouabain are mediated via brain ANGII. Am J Physiol 1996;270:H275-H280.</mixed-citation><mixed-citation xml:lang="en">Huang BS, Leenen FHH. Sympathoexcitatory and pressor responses to increased brain sodium and ouabain are mediated via brain ANGII. Am J Physiol 1996;270:H275-H280.</mixed-citation></citation-alternatives></ref><ref id="cit210"><label>210</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit211"><label>211</label><citation-alternatives><mixed-citation xml:lang="ru">Huang BS, Van Vliet BN, Leenen FH. Increases in CSF [Na+] precede the increases in blood pressure in Dahl S rats and SHR on a high-salt diet. Am J Physiol Heart Circ Physiol 2004;287(3):H1160-H1166.</mixed-citation><mixed-citation xml:lang="en">Huang BS, Van Vliet BN, Leenen FH. Increases in CSF [Na+] precede the increases in blood pressure in Dahl S rats and SHR on a high-salt diet. Am J Physiol Heart Circ Physiol 2004;287(3):H1160-H1166.</mixed-citation></citation-alternatives></ref><ref id="cit212"><label>212</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit213"><label>213</label><citation-alternatives><mixed-citation xml:lang="ru">Wang H, Leenen FH. Brain sodium channels and central sodium-induced increases in brain ouabain-like compound and blood pressure. J Hypertens 2003;21:1519-1524.</mixed-citation><mixed-citation xml:lang="en">Wang H, Leenen FH. Brain sodium channels and central sodium-induced increases in brain ouabain-like compound and blood pressure. J Hypertens 2003;21:1519-1524.</mixed-citation></citation-alternatives></ref><ref id="cit214"><label>214</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit215"><label>215</label><citation-alternatives><mixed-citation xml:lang="ru">Amin MS, Wang HW, Reza E, Whitman SC, Tuana BS, Leenen FH. Distribution of epithelial sodium channels and mineralocorticoid receptors in cardiovascular regulatory centers in rat brain. Am J Physiol Regul Integr Comp Physiol 2005;289(6): R1787-R1797.</mixed-citation><mixed-citation xml:lang="en">Amin MS, Wang HW, Reza E, Whitman SC, Tuana BS, Leenen FH. Distribution of epithelial sodium channels and mineralocorticoid receptors in cardiovascular regulatory centers in rat brain. Am J Physiol Regul Integr Comp Physiol 2005;289(6): R1787-R1797.</mixed-citation></citation-alternatives></ref><ref id="cit216"><label>216</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit217"><label>217</label><citation-alternatives><mixed-citation xml:lang="ru">Orlov SN, Mongin AA. Salt-sensing mechanisms in blood pressure regulation and hypertension. Am J Physiol Heart Circ Physiol 2007;293:H2039-H2053.</mixed-citation><mixed-citation xml:lang="en">Orlov SN, Mongin AA. Salt-sensing mechanisms in blood pressure regulation and hypertension. Am J Physiol Heart Circ Physiol 2007;293:H2039-H2053.</mixed-citation></citation-alternatives></ref><ref id="cit218"><label>218</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit219"><label>219</label><citation-alternatives><mixed-citation xml:lang="ru">Fedorova OV, Doris PA, Bagrov AY. Endogenous marinobufagenin-like factor in acute plasma volume expansion. Clin Exp Hypertens 1998;20(5-6):581-591.</mixed-citation><mixed-citation xml:lang="en">Fedorova OV, Doris PA, Bagrov AY. Endogenous marinobufagenin-like factor in acute plasma volume expansion. Clin Exp Hypertens 1998;20(5-6):581-591.</mixed-citation></citation-alternatives></ref><ref id="cit220"><label>220</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit221"><label>221</label><citation-alternatives><mixed-citation xml:lang="ru">Periyasamy SM, Liu J, Tanta F, Kabak B, Wakefield B, Malhotra D et al. Salt loading induces redistribution of the plasmalemmal Na/K-ATPase in proximal tubule cells. Kidney Int 2005;67(5):1868-1877.</mixed-citation><mixed-citation xml:lang="en">Periyasamy SM, Liu J, Tanta F, Kabak B, Wakefield B, Malhotra D et al. Salt loading induces redistribution of the plasmalemmal Na/K-ATPase in proximal tubule cells. Kidney Int 2005;67(5):1868-1877.</mixed-citation></citation-alternatives></ref><ref id="cit222"><label>222</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit223"><label>223</label><citation-alternatives><mixed-citation xml:lang="ru">Fedorova OV, Bagrov AY. Inhibition of Na/K ATPase from rat aorta by two Na/K pump inhibitors, ouabain and marinobufagenin: evidence of interaction with different alpha-subunit isoforms. Am J Hypertens 1997;10:929-935</mixed-citation><mixed-citation xml:lang="en">Fedorova OV, Bagrov AY. Inhibition of Na/K ATPase from rat aorta by two Na/K pump inhibitors, ouabain and marinobufagenin: evidence of interaction with different alpha-subunit isoforms. Am J Hypertens 1997;10:929-935</mixed-citation></citation-alternatives></ref><ref id="cit224"><label>224</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit225"><label>225</label><citation-alternatives><mixed-citation xml:lang="ru">Dahl LK, Knudsen KD, Iwai J. Humoral transmission of hypertension: evidence from parabiosis. Circ Res 1969; 24(5):(Suppl):S21-S33.</mixed-citation><mixed-citation xml:lang="en">Dahl LK, Knudsen KD, Iwai J. Humoral transmission of hypertension: evidence from parabiosis. Circ Res 1969; 24(5):(Suppl):S21-S33.</mixed-citation></citation-alternatives></ref><ref id="cit226"><label>226</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit227"><label>227</label><citation-alternatives><mixed-citation xml:lang="ru">Liu J, Shapiro JI. Regulation of sodium pump endocytosis by cardiotonic steroids: Molecular mechanisms and physiological implications. Pathophysiology 2007;14:171-181.</mixed-citation><mixed-citation xml:lang="en">Liu J, Shapiro JI. Regulation of sodium pump endocytosis by cardiotonic steroids: Molecular mechanisms and physiological implications. Pathophysiology 2007;14:171-181.</mixed-citation></citation-alternatives></ref><ref id="cit228"><label>228</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit229"><label>229</label><citation-alternatives><mixed-citation xml:lang="ru">Liu J, Periyasamy SM, Gunning W, Fedorova OV, Bagrov AY, Malhotra D et al. Effects of cardiac glycosides on sodium pump expression and function in LLC-PK1 and MDCK cells. Kidney Int 2002;62(6):2118-2125.</mixed-citation><mixed-citation xml:lang="en">Liu J, Periyasamy SM, Gunning W, Fedorova OV, Bagrov AY, Malhotra D et al. Effects of cardiac glycosides on sodium pump expression and function in LLC-PK1 and MDCK cells. Kidney Int 2002;62(6):2118-2125.</mixed-citation></citation-alternatives></ref><ref id="cit230"><label>230</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit231"><label>231</label><citation-alternatives><mixed-citation xml:lang="ru">Oweis S, Wu L, Kiela PR, Zhao H, Malhotra D, Ghishan FK. Cardiac glycoside downregulates NHE3 activity and expression in LLC-PK1 cells. Am J Physiol Renal Physiol 2006;290(5):F997-F1008.</mixed-citation><mixed-citation xml:lang="en">Oweis S, Wu L, Kiela PR, Zhao H, Malhotra D, Ghishan FK. Cardiac glycoside downregulates NHE3 activity and expression in LLC-PK1 cells. Am J Physiol Renal Physiol 2006;290(5):F997-F1008.</mixed-citation></citation-alternatives></ref><ref id="cit232"><label>232</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit233"><label>233</label><citation-alternatives><mixed-citation xml:lang="ru">Cai H et al. () Regulation of apical NHE3 trafficking by ouabain-induced activation of basolateral Na/K-ATPase receptor complex. Am J Physiol Cell Physiol 2008;294:C555-C563.</mixed-citation><mixed-citation xml:lang="en">Cai H et al. () Regulation of apical NHE3 trafficking by ouabain-induced activation of basolateral Na/K-ATPase receptor complex. Am J Physiol Cell Physiol 2008;294:C555-C563.</mixed-citation></citation-alternatives></ref><ref id="cit234"><label>234</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit235"><label>235</label><citation-alternatives><mixed-citation xml:lang="ru">Schrier RW, Abraham WT. Hormones and hemodynamics in heart failure. N Engl J Med 1999;341:577-585.</mixed-citation><mixed-citation xml:lang="en">Schrier RW, Abraham WT. Hormones and hemodynamics in heart failure. N Engl J Med 1999;341:577-585.</mixed-citation></citation-alternatives></ref><ref id="cit236"><label>236</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit237"><label>237</label><citation-alternatives><mixed-citation xml:lang="ru">Schreiber V, Kцlbel F, Stĕpбn J, Gregorovб I, Pribyl T. Digoxin-like immunoreactivity in the serum of rats with cardiac overload. J Mol Cell Cardiol 1981;13(1):107-110.</mixed-citation><mixed-citation xml:lang="en">Schreiber V, Kцlbel F, Stĕpбn J, Gregorovб I, Pribyl T. Digoxin-like immunoreactivity in the serum of rats with cardiac overload. J Mol Cell Cardiol 1981;13(1):107-110.</mixed-citation></citation-alternatives></ref><ref id="cit238"><label>238</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit239"><label>239</label><citation-alternatives><mixed-citation xml:lang="ru">Morise T, Okamoto S, Takasaki H, Ikeda M, Takeda R, Kiuti F, Tuda Y. Biological activity of partially purified digitalis-like substance and Na-K-ATPase inhibitor in rats. Jpn Circ J 1988;52(11):1309-1316.</mixed-citation><mixed-citation xml:lang="en">Morise T, Okamoto S, Takasaki H, Ikeda M, Takeda R, Kiuti F, Tuda Y. Biological activity of partially purified digitalis-like substance and Na-K-ATPase inhibitor in rats. Jpn Circ J 1988;52(11):1309-1316.</mixed-citation></citation-alternatives></ref><ref id="cit240"><label>240</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit241"><label>241</label><citation-alternatives><mixed-citation xml:lang="ru">Liu ZQ, Ma AQ, Zhang L, Yang DY. Intra-cellular electrolyte changes and levels of endogenous digoxin-like substance within the plasma in patients with congestive heart failure. Int J Cardiol 1990;27(1):47-53.</mixed-citation><mixed-citation xml:lang="en">Liu ZQ, Ma AQ, Zhang L, Yang DY. Intra-cellular electrolyte changes and levels of endogenous digoxin-like substance within the plasma in patients with congestive heart failure. Int J Cardiol 1990;27(1):47-53.</mixed-citation></citation-alternatives></ref><ref id="cit242"><label>242</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit243"><label>243</label><citation-alternatives><mixed-citation xml:lang="ru">Gottlieb SS, Rogowski AC, Weinberg M, Krichten CM, Hamilton BP, Hamlyn JM. Elevated concentrations of endogenous ouabain in patients with congestive heart failure. Circulation 1992;86(2):420-425.</mixed-citation><mixed-citation xml:lang="en">Gottlieb SS, Rogowski AC, Weinberg M, Krichten CM, Hamilton BP, Hamlyn JM. Elevated concentrations of endogenous ouabain in patients with congestive heart failure. Circulation 1992;86(2):420-425.</mixed-citation></citation-alternatives></ref><ref id="cit244"><label>244</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit245"><label>245</label><citation-alternatives><mixed-citation xml:lang="ru">Manunta P, Stella P, Rivera R, Ciurlino D, Cusi D, Ferrandi M et al. Left ventricular mass, stroke volume, and ouabain-like factor in essential hypertension. Hypertension 1999;34(3):450 456</mixed-citation><mixed-citation xml:lang="en">Manunta P, Stella P, Rivera R, Ciurlino D, Cusi D, Ferrandi M et al. Left ventricular mass, stroke volume, and ouabain-like factor in essential hypertension. Hypertension 1999;34(3):450 456</mixed-citation></citation-alternatives></ref><ref id="cit246"><label>246</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit247"><label>247</label><citation-alternatives><mixed-citation xml:lang="ru">Pierdomenico SD, Bucci A, Manunta P, Rivera R, Ferrandi M, Hamlyn JM et al. Endogenous ouabain and hemodynamic and left ventricular geometric patterns in essential hypertension. Am J Hypertens 2001;14(1):44-50.</mixed-citation><mixed-citation xml:lang="en">Pierdomenico SD, Bucci A, Manunta P, Rivera R, Ferrandi M, Hamlyn JM et al. Endogenous ouabain and hemodynamic and left ventricular geometric patterns in essential hypertension. Am J Hypertens 2001;14(1):44-50.</mixed-citation></citation-alternatives></ref><ref id="cit248"><label>248</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit249"><label>249</label><citation-alternatives><mixed-citation xml:lang="ru">Balzan S, Neglia D, Ghione S, D'Urso G, Baldacchino MC, Montali U, L'Abbate A. Increased circulating levels of ouabain-like factor in patients with asymptomatic left ventricular dysfunction. Eur J Heart Fail 2001;3(2):165-171.</mixed-citation><mixed-citation xml:lang="en">Balzan S, Neglia D, Ghione S, D'Urso G, Baldacchino MC, Montali U, L'Abbate A. Increased circulating levels of ouabain-like factor in patients with asymptomatic left ventricular dysfunction. Eur J Heart Fail 2001;3(2):165-171.</mixed-citation></citation-alternatives></ref><ref id="cit250"><label>250</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit251"><label>251</label><citation-alternatives><mixed-citation xml:lang="ru">Pitzalis MV, Hamlyn JM, Messaggio E, Iacoviello M, Forleo C, Romito R et al. Independent and incremental prognostic value of endogenous ouabain in idiopathic dilated cardiomyopathy. Eur J Heart Fail 2006;8(2): 179-186.</mixed-citation><mixed-citation xml:lang="en">Pitzalis MV, Hamlyn JM, Messaggio E, Iacoviello M, Forleo C, Romito R et al. Independent and incremental prognostic value of endogenous ouabain in idiopathic dilated cardiomyopathy. Eur J Heart Fail 2006;8(2): 179-186.</mixed-citation></citation-alternatives></ref><ref id="cit252"><label>252</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit253"><label>253</label><citation-alternatives><mixed-citation xml:lang="ru">Stella P, Manunta P, Mallamaci F, Melandri M, Spotti D, Tripepi G et al. Endogenous ouabain and cardiomyopathy in dialysis patients. J Intern Med 2008;263(3):274-280</mixed-citation><mixed-citation xml:lang="en">Stella P, Manunta P, Mallamaci F, Melandri M, Spotti D, Tripepi G et al. Endogenous ouabain and cardiomyopathy in dialysis patients. J Intern Med 2008;263(3):274-280</mixed-citation></citation-alternatives></ref><ref id="cit254"><label>254</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit255"><label>255</label><citation-alternatives><mixed-citation xml:lang="ru">Fedorova OV, Talan MI, Agalakova NI, Lakatta EG, Bagrov AY. Coordinated shifts in Na/K-ATPase isoforms and their endogenous ligands during cardiac hypertrophy and failure in NaCl sensitive hypertension. J Hypertens 2004;22(2):389-397.</mixed-citation><mixed-citation xml:lang="en">Fedorova OV, Talan MI, Agalakova NI, Lakatta EG, Bagrov AY. Coordinated shifts in Na/K-ATPase isoforms and their endogenous ligands during cardiac hypertrophy and failure in NaCl sensitive hypertension. J Hypertens 2004;22(2):389-397.</mixed-citation></citation-alternatives></ref><ref id="cit256"><label>256</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit257"><label>257</label><citation-alternatives><mixed-citation xml:lang="ru">Akimova OA, Bagrov AY, Lopina OD, Kamernitsky AV, Tremblay J, Hamet P, Orlov SN. Cardiotonic steroids differentially affect intracellular Na+ and [Na+]i/[K+]i independent signaling in C7-MDCK cells. J Biol Chem 2005;280(1):832-839.</mixed-citation><mixed-citation xml:lang="en">Akimova OA, Bagrov AY, Lopina OD, Kamernitsky AV, Tremblay J, Hamet P, Orlov SN. Cardiotonic steroids differentially affect intracellular Na+ and [Na+]i/[K+]i independent signaling in C7-MDCK cells. J Biol Chem 2005;280(1):832-839.</mixed-citation></citation-alternatives></ref><ref id="cit258"><label>258</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit259"><label>259</label><citation-alternatives><mixed-citation xml:lang="ru">Neuss M, Crow MT, Chesley A, Lakatta EG. Apoptosis in cardiac disease what is it-how does it occur. Cardiovasc Drugs Ther 2001;15(6):507-523.</mixed-citation><mixed-citation xml:lang="en">Neuss M, Crow MT, Chesley A, Lakatta EG. Apoptosis in cardiac disease what is it-how does it occur. Cardiovasc Drugs Ther 2001;15(6):507-523.</mixed-citation></citation-alternatives></ref><ref id="cit260"><label>260</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit261"><label>261</label><citation-alternatives><mixed-citation xml:lang="ru">Mohmand B, Malhotra DK, Shapiro JI. Uremic cardiomyopathy: role of circulating digitalis like substances. Front Biosci 2005;10:2036-2044.</mixed-citation><mixed-citation xml:lang="en">Mohmand B, Malhotra DK, Shapiro JI. Uremic cardiomyopathy: role of circulating digitalis like substances. Front Biosci 2005;10:2036-2044.</mixed-citation></citation-alternatives></ref><ref id="cit262"><label>262</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit263"><label>263</label><citation-alternatives><mixed-citation xml:lang="ru">dleton RJ, Parfrey PS, Foley RN. Left ventricular hypertrophy in the renal patient. J Am Soc Nephrol 2001; 12(5): 1079-1084.</mixed-citation><mixed-citation xml:lang="en">dleton RJ, Parfrey PS, Foley RN. Left ventricular hypertrophy in the renal patient. J Am Soc Nephrol 2001; 12(5): 1079-1084.</mixed-citation></citation-alternatives></ref><ref id="cit264"><label>264</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit265"><label>265</label><citation-alternatives><mixed-citation xml:lang="ru">Kennedy D, Omran E, Periyasamy SM, Nadoor J, Priyadarshi A, Willey JC et al. Effect of chronic renal failure on cardiac contractile function, calcium cycling, and gene expression of proteins important for calcium homeostasis in the rat. J Am Soc Nephrol 2003;14(1):90-97.</mixed-citation><mixed-citation xml:lang="en">Kennedy D, Omran E, Periyasamy SM, Nadoor J, Priyadarshi A, Willey JC et al. Effect of chronic renal failure on cardiac contractile function, calcium cycling, and gene expression of proteins important for calcium homeostasis in the rat. J Am Soc Nephrol 2003;14(1):90-97.</mixed-citation></citation-alternatives></ref><ref id="cit266"><label>266</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit267"><label>267</label><citation-alternatives><mixed-citation xml:lang="ru">Kennedy DJ, Elkareh J, Shidyak A, Shapiro AP, Smaili S, Mutgi К et al. Partial nephrectomy as a model for uremic cardiomyopathy in the mouse. Am J Physiol Renal Physiol 2008;294(2):F450-F454.</mixed-citation><mixed-citation xml:lang="en">Kennedy DJ, Elkareh J, Shidyak A, Shapiro AP, Smaili S, Mutgi К et al. Partial nephrectomy as a model for uremic cardiomyopathy in the mouse. Am J Physiol Renal Physiol 2008;294(2):F450-F454.</mixed-citation></citation-alternatives></ref><ref id="cit268"><label>268</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit269"><label>269</label><citation-alternatives><mixed-citation xml:lang="ru">Elkareh J, Kennedy DJ, Yashaswi B, Vetteth S, Shidyak A, Kim EG et al. Marinobufagenin stimulates fibroblast collagen production and causes fibrosis in experimental uremic cardiomyopathy. Hypertension 2007;49(1):215-224.</mixed-citation><mixed-citation xml:lang="en">Elkareh J, Kennedy DJ, Yashaswi B, Vetteth S, Shidyak A, Kim EG et al. Marinobufagenin stimulates fibroblast collagen production and causes fibrosis in experimental uremic cardiomyopathy. Hypertension 2007;49(1):215-224.</mixed-citation></citation-alternatives></ref><ref id="cit270"><label>270</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit271"><label>271</label><citation-alternatives><mixed-citation xml:lang="ru">Kennedy DJ, Vetteth S, Periyasamy SM, Kanj M, Fedorova L, Khouri S et al. Central role for the cardiotonic steroid marinobufagenin in the pathogenesis of experimental uremic cardiomyopathy. Hypertension 2006;47(3):488-495.</mixed-citation><mixed-citation xml:lang="en">Kennedy DJ, Vetteth S, Periyasamy SM, Kanj M, Fedorova L, Khouri S et al. Central role for the cardiotonic steroid marinobufagenin in the pathogenesis of experimental uremic cardiomyopathy. Hypertension 2006;47(3):488-495.</mixed-citation></citation-alternatives></ref><ref id="cit272"><label>272</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit273"><label>273</label><citation-alternatives><mixed-citation xml:lang="ru">London GM. Left ventricular alterations and end-stage renal disease. Nephrol Dial Transplant 2002; 17 (Suppl 1): S29-S36.</mixed-citation><mixed-citation xml:lang="en">London GM. Left ventricular alterations and end-stage renal disease. Nephrol Dial Transplant 2002; 17 (Suppl 1): S29-S36.</mixed-citation></citation-alternatives></ref><ref id="cit274"><label>274</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit275"><label>275</label><citation-alternatives><mixed-citation xml:lang="ru">Gallery ED, Hunyor SN, Gyцry AZ. Plasma volume contraction: a significant factor in both pregnancy-associated hypertension (pre-eclampsia) and chronic hypertension in pregnancy. QJ Med 1979;48(192):593-602.</mixed-citation><mixed-citation xml:lang="en">Gallery ED, Hunyor SN, Gyцry AZ. Plasma volume contraction: a significant factor in both pregnancy-associated hypertension (pre-eclampsia) and chronic hypertension in pregnancy. QJ Med 1979;48(192):593-602.</mixed-citation></citation-alternatives></ref><ref id="cit276"><label>276</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit277"><label>277</label><citation-alternatives><mixed-citation xml:lang="ru">Masilamani S, Baylis. Pregnant rats are refractory to the natriuretic actions of ANP. Am J Physiol 1994;267:R1611-R1616.</mixed-citation><mixed-citation xml:lang="en">Masilamani S, Baylis. Pregnant rats are refractory to the natriuretic actions of ANP. Am J Physiol 1994;267:R1611-R1616.</mixed-citation></citation-alternatives></ref><ref id="cit278"><label>278</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit279"><label>279</label><citation-alternatives><mixed-citation xml:lang="ru">Graves SW. The possible role of digitalis-like factors in pregnancy-induced hypertension. Hypertension 1987;10(5 Pt 2): 184-186.</mixed-citation><mixed-citation xml:lang="en">Graves SW. The possible role of digitalis-like factors in pregnancy-induced hypertension. Hypertension 1987;10(5 Pt 2): 184-186.</mixed-citation></citation-alternatives></ref><ref id="cit280"><label>280</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit281"><label>281</label><citation-alternatives><mixed-citation xml:lang="ru">Graves SW, Valdes R Jr, Brown BA, Knight AB, Craig HR. Endogenous digoxin immunoreactive substance in human pregnancies. J Clin Endocrinol Metab 1984;58(4): 748-751.</mixed-citation><mixed-citation xml:lang="en">Graves SW, Valdes R Jr, Brown BA, Knight AB, Craig HR. Endogenous digoxin immunoreactive substance in human pregnancies. J Clin Endocrinol Metab 1984;58(4): 748-751.</mixed-citation></citation-alternatives></ref><ref id="cit282"><label>282</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit283"><label>283</label><citation-alternatives><mixed-citation xml:lang="ru">Averina IV, Tapilskaya NI, Reznik VA, Frolova EV, Fedorova OV, Lakatta EG, Bagrov AY. Endogenous Na/K-ATPase inhibitors in patients with preeclampsia. Cell Mol Biol (Noisy-legrand) 2006;52(8): 19-23.</mixed-citation><mixed-citation xml:lang="en">Averina IV, Tapilskaya NI, Reznik VA, Frolova EV, Fedorova OV, Lakatta EG, Bagrov AY. Endogenous Na/K-ATPase inhibitors in patients with preeclampsia. Cell Mol Biol (Noisy-legrand) 2006;52(8): 19-23.</mixed-citation></citation-alternatives></ref><ref id="cit284"><label>284</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit285"><label>285</label><citation-alternatives><mixed-citation xml:lang="ru">Goodlin RC. Antidigoxin antibodies in eclampsia. N Engl J Med 1988;318:518-519.</mixed-citation><mixed-citation xml:lang="en">Goodlin RC. Antidigoxin antibodies in eclampsia. N Engl J Med 1988;318:518-519.</mixed-citation></citation-alternatives></ref><ref id="cit286"><label>286</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit287"><label>287</label><citation-alternatives><mixed-citation xml:lang="ru">Adair CD, Buckalew V, Taylor K, Ernest JM, Frye AH, Evans C, Veille JC. Elevated endoxin-like factor complicating a multifetal second trimester pregnancy: treatment with digoxin-binding immunoglobulin. Am J Nephrol 1996;16(6):529-531.</mixed-citation><mixed-citation xml:lang="en">Adair CD, Buckalew V, Taylor K, Ernest JM, Frye AH, Evans C, Veille JC. Elevated endoxin-like factor complicating a multifetal second trimester pregnancy: treatment with digoxin-binding immunoglobulin. Am J Nephrol 1996;16(6):529-531.</mixed-citation></citation-alternatives></ref><ref id="cit288"><label>288</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit289"><label>289</label><citation-alternatives><mixed-citation xml:lang="ru">Adair D et al. Effects of Fab digoxin-specific antibodies on mean arterial pressure in severe preeclampsia [abstract]. Am J Hypertens 1997;10:11A.</mixed-citation><mixed-citation xml:lang="en">Adair D et al. Effects of Fab digoxin-specific antibodies on mean arterial pressure in severe preeclampsia [abstract]. Am J Hypertens 1997;10:11A.</mixed-citation></citation-alternatives></ref><ref id="cit290"><label>290</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit291"><label>291</label><citation-alternatives><mixed-citation xml:lang="ru">Di Grande A, Boura AL, Read MA, Malatino LS, Walters WA. Release of a substance from the human placenta having digoxin-like immunoreactivity. Clin Exp Pharmacol Physiol 1993;20(9):603-607</mixed-citation><mixed-citation xml:lang="en">Di Grande A, Boura AL, Read MA, Malatino LS, Walters WA. Release of a substance from the human placenta having digoxin-like immunoreactivity. Clin Exp Pharmacol Physiol 1993;20(9):603-607</mixed-citation></citation-alternatives></ref><ref id="cit292"><label>292</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit293"><label>293</label><citation-alternatives><mixed-citation xml:lang="ru">Amler E, Cester N, Salvolini E, Staffolani R, Burkhard M, Mazzanti L et al. Human hypertensive placenta contains an increased amount of Na,K-ATPase with higher affinity for cardiac glycosides. Cell Biol Int 1994;18(7):723-727.</mixed-citation><mixed-citation xml:lang="en">Amler E, Cester N, Salvolini E, Staffolani R, Burkhard M, Mazzanti L et al. Human hypertensive placenta contains an increased amount of Na,K-ATPase with higher affinity for cardiac glycosides. Cell Biol Int 1994;18(7):723-727.</mixed-citation></citation-alternatives></ref><ref id="cit294"><label>294</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit295"><label>295</label><citation-alternatives><mixed-citation xml:lang="ru">Dmitrieva RI, Bagrov AY, Lalli E, Sassone-Corsi P, Stocco DM, Doris PA. Mammalian bufadienolide is synthesized from cholesterol in the adrenal cortex by a pathway that is independent of cholesterol side chain cleavage. Hypertension 2000;36(3):442-448.</mixed-citation><mixed-citation xml:lang="en">Dmitrieva RI, Bagrov AY, Lalli E, Sassone-Corsi P, Stocco DM, Doris PA. Mammalian bufadienolide is synthesized from cholesterol in the adrenal cortex by a pathway that is independent of cholesterol side chain cleavage. Hypertension 2000;36(3):442-448.</mixed-citation></citation-alternatives></ref><ref id="cit296"><label>296</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit297"><label>297</label><citation-alternatives><mixed-citation xml:lang="ru">Fedorova OV, Kolodkin NI, Agalakova NI, Namikas AR, Bzhelyansky A, St-Louis J et al. Antibody to marinobufagenin lowers blood pressure in pregnant rats on a high NaCl intake. J Hypertens 2005;23(4):835-842.</mixed-citation><mixed-citation xml:lang="en">Fedorova OV, Kolodkin NI, Agalakova NI, Namikas AR, Bzhelyansky A, St-Louis J et al. Antibody to marinobufagenin lowers blood pressure in pregnant rats on a high NaCl intake. J Hypertens 2005;23(4):835-842.</mixed-citation></citation-alternatives></ref><ref id="cit298"><label>298</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit299"><label>299</label><citation-alternatives><mixed-citation xml:lang="ru">Vu HV, Ianosi-Irimie MR, Pridjian CA, Whitbred JM, Durst JM, Bagrov AY et al. Involvement of marinobufagenin in a rat model of human preeclampsia. Am J Nephrol 2005;25(5):520-528.</mixed-citation><mixed-citation xml:lang="en">Vu HV, Ianosi-Irimie MR, Pridjian CA, Whitbred JM, Durst JM, Bagrov AY et al. Involvement of marinobufagenin in a rat model of human preeclampsia. Am J Nephrol 2005;25(5):520-528.</mixed-citation></citation-alternatives></ref><ref id="cit300"><label>300</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit301"><label>301</label><citation-alternatives><mixed-citation xml:lang="ru">LaMarca HL, Morris CA, Pettit GR, Nagowa T, Puschett JB. Marinobufagenin impairs first trimester cytotrophoblast differentiation. Placenta 2006;27(9-10):984-988</mixed-citation><mixed-citation xml:lang="en">LaMarca HL, Morris CA, Pettit GR, Nagowa T, Puschett JB. Marinobufagenin impairs first trimester cytotrophoblast differentiation. Placenta 2006;27(9-10):984-988</mixed-citation></citation-alternatives></ref><ref id="cit302"><label>302</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit303"><label>303</label><citation-alternatives><mixed-citation xml:lang="ru">Weidemann H, Salomon N, Avnit-Sagi T, Weidenfeld J, Rosen H, Lichtstein D. Diverse effects of stress and additional adrenocorticotropic hormone on digitalis-like compounds in normal and nude mice. J Neuroendocrinol 2004;16(5):458-463.</mixed-citation><mixed-citation xml:lang="en">Weidemann H, Salomon N, Avnit-Sagi T, Weidenfeld J, Rosen H, Lichtstein D. Diverse effects of stress and additional adrenocorticotropic hormone on digitalis-like compounds in normal and nude mice. J Neuroendocrinol 2004;16(5):458-463.</mixed-citation></citation-alternatives></ref><ref id="cit304"><label>304</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit305"><label>305</label><citation-alternatives><mixed-citation xml:lang="ru">Bauer N, Mьller-Ehmsen J, Кrдmеr U, Hambarchian N, Zobel C, Schwinger RH et al. Ouabain-like compound changes rapidly on physical exercise in humans and dogs: effects of beta-blockade and angiotensin-converting enzyme inhibition. Hypertension 2005;45(5):1024-1028.</mixed-citation><mixed-citation xml:lang="en">Bauer N, Mьller-Ehmsen J, Кrдmеr U, Hambarchian N, Zobel C, Schwinger RH et al. Ouabain-like compound changes rapidly on physical exercise in humans and dogs: effects of beta-blockade and angiotensin-converting enzyme inhibition. Hypertension 2005;45(5):1024-1028.</mixed-citation></citation-alternatives></ref><ref id="cit306"><label>306</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit307"><label>307</label><citation-alternatives><mixed-citation xml:lang="ru">Bagrov AY, Fedorova OV, Roukoyatkina NI, Zhabko EP. Effect of antidigoxin antibody on myocardial Na,K pump activity and on endogenous digoxin like factor in acute myocardial ischemia in rats. Cardiovasc Res 1993;27(6): 1045-1050.</mixed-citation><mixed-citation xml:lang="en">Bagrov AY, Fedorova OV, Roukoyatkina NI, Zhabko EP. Effect of antidigoxin antibody on myocardial Na,K pump activity and on endogenous digoxin like factor in acute myocardial ischemia in rats. Cardiovasc Res 1993;27(6): 1045-1050.</mixed-citation></citation-alternatives></ref><ref id="cit308"><label>308</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit309"><label>309</label><citation-alternatives><mixed-citation xml:lang="ru">Grider G, El-Mallakh RS, Huff MO, Buss TJ, Miller J, Valdes R Jr. Endogenous digoxin-like immunoreactive factor (DLIF) serum concentrations are decreased in manic bipolar patients compared to normal controls. J Affect Disord 1999;54(3):261-267.</mixed-citation><mixed-citation xml:lang="en">Grider G, El-Mallakh RS, Huff MO, Buss TJ, Miller J, Valdes R Jr. Endogenous digoxin-like immunoreactive factor (DLIF) serum concentrations are decreased in manic bipolar patients compared to normal controls. J Affect Disord 1999;54(3):261-267.</mixed-citation></citation-alternatives></ref><ref id="cit310"><label>310</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit311"><label>311</label><citation-alternatives><mixed-citation xml:lang="ru">Goldstein I, Levy T, Galili D, Ovadia H, Yirmiya R, Rosen H, Lichtstein D. Involvement of Na(+), K(+)- ATPase and endogenous digitalis-like compounds in depressive disorders. Biol Psychiatry 2006;60(5): 491-499.</mixed-citation><mixed-citation xml:lang="en">Goldstein I, Levy T, Galili D, Ovadia H, Yirmiya R, Rosen H, Lichtstein D. Involvement of Na(+), K(+)- ATPase and endogenous digitalis-like compounds in depressive disorders. Biol Psychiatry 2006;60(5): 491-499.</mixed-citation></citation-alternatives></ref><ref id="cit312"><label>312</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit313"><label>313</label><citation-alternatives><mixed-citation xml:lang="ru">Bagrov YY, Dmitrieva NI, Manusova NB, Zvartau ЕЕ, Patkina NA, Bagrov AY. Involvement of endogenous digitalis-like factors in voluntary selection of alcohol by rats. Life Sci 1999;64(20):PL219-PL225.</mixed-citation><mixed-citation xml:lang="en">Bagrov YY, Dmitrieva NI, Manusova NB, Zvartau ЕЕ, Patkina NA, Bagrov AY. Involvement of endogenous digitalis-like factors in voluntary selection of alcohol by rats. Life Sci 1999;64(20):PL219-PL225.</mixed-citation></citation-alternatives></ref><ref id="cit314"><label>314</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit315"><label>315</label><citation-alternatives><mixed-citation xml:lang="ru">Clerico A, Giampietro O. Is the endogenous digitalis-like factor the link between hypertension and metabolic disorders as diabetes mellitus, obesity and acromegaly? Clin Physiol Biochem 1990;8:153-168.</mixed-citation><mixed-citation xml:lang="en">Clerico A, Giampietro O. Is the endogenous digitalis-like factor the link between hypertension and metabolic disorders as diabetes mellitus, obesity and acromegaly? Clin Physiol Biochem 1990;8:153-168.</mixed-citation></citation-alternatives></ref><ref id="cit316"><label>316</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit317"><label>317</label><citation-alternatives><mixed-citation xml:lang="ru">Chen S, Yuan C, Clough D, Schooley J, Haddy FJ, Pamnani MB. Role of digitalis-like substance in the hypertension of streptozotocin-induced diabetes in reduced renal mass rats. Am J Hypertens 1993;6(5 Pt 1):397-406.</mixed-citation><mixed-citation xml:lang="en">Chen S, Yuan C, Clough D, Schooley J, Haddy FJ, Pamnani MB. Role of digitalis-like substance in the hypertension of streptozotocin-induced diabetes in reduced renal mass rats. Am J Hypertens 1993;6(5 Pt 1):397-406.</mixed-citation></citation-alternatives></ref><ref id="cit318"><label>318</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit319"><label>319</label><citation-alternatives><mixed-citation xml:lang="ru">Bagrov YY, Manusova NB, Egorova IA, Fedorova OV, Bagrov AY. Endogenous digitalis-like ligands and Na/K-ATPase inhibition in experimental diabetes mellitus. Front Biosci 2005;10:2257-2262.</mixed-citation><mixed-citation xml:lang="en">Bagrov YY, Manusova NB, Egorova IA, Fedorova OV, Bagrov AY. Endogenous digitalis-like ligands and Na/K-ATPase inhibition in experimental diabetes mellitus. Front Biosci 2005;10:2257-2262.</mixed-citation></citation-alternatives></ref><ref id="cit320"><label>320</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit321"><label>321</label><citation-alternatives><mixed-citation xml:lang="ru">Carroll JS, Seely EW, Tao QF, Graves SW. Digitalis-like factor response to hyperinsulinemia accompanying a euglycemic hyperinsulinemic clamp or oral glucose tolerance test. Life Sci 2001;69(7):829-837.</mixed-citation><mixed-citation xml:lang="en">Carroll JS, Seely EW, Tao QF, Graves SW. Digitalis-like factor response to hyperinsulinemia accompanying a euglycemic hyperinsulinemic clamp or oral glucose tolerance test. Life Sci 2001;69(7):829-837.</mixed-citation></citation-alternatives></ref><ref id="cit322"><label>322</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit323"><label>323</label><citation-alternatives><mixed-citation xml:lang="ru">Weidemann H. Na/K-ATPase, endogenous digitalis like compounds and cancer development-a hypothesis. Front Biosci 2005;10:2165-2176.</mixed-citation><mixed-citation xml:lang="en">Weidemann H. Na/K-ATPase, endogenous digitalis like compounds and cancer development-a hypothesis. Front Biosci 2005;10:2165-2176.</mixed-citation></citation-alternatives></ref><ref id="cit324"><label>324</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit325"><label>325</label><citation-alternatives><mixed-citation xml:lang="ru">Mijatovic T, Van Quaquebeke E, Delest B, Debeir O, Darro F, Kiss R. Cardiotonic steroids on the road to anti-cancer therapy. Biochim Biophys Acta 2007;1776(1): 32-57.</mixed-citation><mixed-citation xml:lang="en">Mijatovic T, Van Quaquebeke E, Delest B, Debeir O, Darro F, Kiss R. Cardiotonic steroids on the road to anti-cancer therapy. Biochim Biophys Acta 2007;1776(1): 32-57.</mixed-citation></citation-alternatives></ref><ref id="cit326"><label>326</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit327"><label>327</label><citation-alternatives><mixed-citation xml:lang="ru">Ferrandi M, Barassi P, Molinari I, Torielli L, Tripodi G, Minotti E et al. Ouabain antagonists as antihypertensive agents. Curr Pharm Des 2005;11(25):3301-3305.</mixed-citation><mixed-citation xml:lang="en">Ferrandi M, Barassi P, Molinari I, Torielli L, Tripodi G, Minotti E et al. Ouabain antagonists as antihypertensive agents. Curr Pharm Des 2005;11(25):3301-3305.</mixed-citation></citation-alternatives></ref><ref id="cit328"><label>328</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit329"><label>329</label><citation-alternatives><mixed-citation xml:lang="ru">ClinicalTrials.gov. Efficacy of Rostafuroxin in the treatment of essential hypertension. [http://clinicaltrials.gov/ct2/show/NCT00415038] online 2006.</mixed-citation><mixed-citation xml:lang="en">ClinicalTrials.gov. Efficacy of Rostafuroxin in the treatment of essential hypertension. [http://clinicaltrials.gov/ct2/show/NCT00415038] online 2006.</mixed-citation></citation-alternatives></ref><ref id="cit330"><label>330</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit331"><label>331</label><citation-alternatives><mixed-citation xml:lang="ru">Finotti P, Palatini P. Canrenone as a partial agonist at the digitalis receptor site of sodium potassium-activated adenosine triphosphatase. J Pharmacol Exp Ther 1981;217:784-790.</mixed-citation><mixed-citation xml:lang="en">Finotti P, Palatini P. Canrenone as a partial agonist at the digitalis receptor site of sodium potassium-activated adenosine triphosphatase. J Pharmacol Exp Ther 1981;217:784-790.</mixed-citation></citation-alternatives></ref><ref id="cit332"><label>332</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit333"><label>333</label><citation-alternatives><mixed-citation xml:lang="ru">de Mendonзa M, Grichois ML, Pernollet MG, Wauquier I, Trouillet-Thormann B, Meyer P, Devynck MA, Garay R. Antihypertensive effect of canrenone in a model where endogenous ouabainlike factors are present. J Cardiovasc Pharmacol 1988;11(1):75-83.</mixed-citation><mixed-citation xml:lang="en">de Mendonзa M, Grichois ML, Pernollet MG, Wauquier I, Trouillet-Thormann B, Meyer P, Devynck MA, Garay R. Antihypertensive effect of canrenone in a model where endogenous ouabainlike factors are present. J Cardiovasc Pharmacol 1988;11(1):75-83.</mixed-citation></citation-alternatives></ref><ref id="cit334"><label>334</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit335"><label>335</label><citation-alternatives><mixed-citation xml:lang="ru">Waldorff S, Buch J. Canrenoate-a spironolactone metabolite: acute cardiac effects in digitalized patients. Eur J Cardiol 1979;10:143-149.</mixed-citation><mixed-citation xml:lang="en">Waldorff S, Buch J. Canrenoate-a spironolactone metabolite: acute cardiac effects in digitalized patients. Eur J Cardiol 1979;10:143-149.</mixed-citation></citation-alternatives></ref><ref id="cit336"><label>336</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit337"><label>337</label><citation-alternatives><mixed-citation xml:lang="ru">Lam G et al. Antepartum administration of a digoxin immune Fab (Digibind®) improves renal function in patients with severe preeclampsia. Proceedings of XVI congress of International Society for the Study of Hypertension in Pregnancy. Washington DC 2008; 44:60.</mixed-citation><mixed-citation xml:lang="en">Lam G et al. Antepartum administration of a digoxin immune Fab (Digibind®) improves renal function in patients with severe preeclampsia. Proceedings of XVI congress of International Society for the Study of Hypertension in Pregnancy. Washington DC 2008; 44:60.</mixed-citation></citation-alternatives></ref><ref id="cit338"><label>338</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit339"><label>339</label><citation-alternatives><mixed-citation xml:lang="ru">Menezes JC, Troster EJ, Dichtchekenian V. Digoxin antibody decreases natriuresis and diuresis in cerebral hemorrhage. Intensive Care Med 2003;29(12):2291-2296.</mixed-citation><mixed-citation xml:lang="en">Menezes JC, Troster EJ, Dichtchekenian V. Digoxin antibody decreases natriuresis and diuresis in cerebral hemorrhage. Intensive Care Med 2003;29(12):2291-2296.</mixed-citation></citation-alternatives></ref><ref id="cit340"><label>340</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit341"><label>341</label><citation-alternatives><mixed-citation xml:lang="ru">Fedorova OV et al. Reduction in myocardial PKC в2, Na/K-ATPase sensitivity to marinobufagenin and blood pressure in response to cicletanine. Hypertension 2003;41:505-511.</mixed-citation><mixed-citation xml:lang="en">Fedorova OV et al. Reduction in myocardial PKC в2, Na/K-ATPase sensitivity to marinobufagenin and blood pressure in response to cicletanine. Hypertension 2003;41:505-511.</mixed-citation></citation-alternatives></ref><ref id="cit342"><label>342</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit343"><label>343</label><citation-alternatives><mixed-citation xml:lang="ru">Fedorova OV, Agalakova NI, Morrell CH, Lakatta EG, Bagrov AY. ANP differentially modulates marinobufagenin-induced sodium pump inhibition in kidney and aorta. Hypertension 2006;48(6):1160-1168.</mixed-citation><mixed-citation xml:lang="en">Fedorova OV, Agalakova NI, Morrell CH, Lakatta EG, Bagrov AY. ANP differentially modulates marinobufagenin-induced sodium pump inhibition in kidney and aorta. Hypertension 2006;48(6):1160-1168.</mixed-citation></citation-alternatives></ref><ref id="cit344"><label>344</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
